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Following natural or experimental infection, and in cell culture, coxsackie B virus
(CVB) RNA can persist for weeks in the absence of CPE yet with detectable viral RNA.
Earlier studies in our laboratory demonstrated that this persistence produced viral RNA
with up to 49 nucleotide deletions at the 5’ genomic terminus, partially degrading the
cloverleaf (or domain I), an RNA structure that is required for efficient viral replication. A
cis-acting replication element (CRE) in the 2C protein coding region [CRE(2C)]
templates the addition of two uridine residues to the virus-encoded RNA replication
primer, VPg, prior to genomic replication. Because our previous work also demonstrated
that 5’ terminally deleted CVB (CVB-TD) genomes have VPg covalently linked despite
rarely terminating in the canonical UU donated by CRE(2C) mediated uridylylation of
VPg, it was hypothesized that a functional (uridylylating) CRE(2C) would be
unnecessary for CVB-TD replication.
Using the same 16 mutations in the CVB3 CRE(2C) structure that were
considered lethal for this virus by others, this work demonstrates that the wild type (wt)
and the CVB3-TD virus carrying these mutations are viable with a non-uridylylating
CRE(2C) in infected cell cultures and in mice. While the wt genome with the mutated

CRE(2C) displays suppressed replication levels similar to that observed in a CVB3-TD
strain, mutation of CRE(2C) function in a CVB3-TD strain does not further decrease
replication. Further, this work shows that replication of the parental CVB3 strain
containing the mutated CRE(2C) drives de novo generation of 5' terminal genomic
deletions, and that the 16 mutations introduced into the CRE(2C) region can revert
completely to wt sequence after only eight days of replication in cell culture.
Cumulatively, these findings demonstrate that VPg can prime without being specifically
uridylylated and that this priming is error prone, resulting in loss of 5' terminal sequence
information. Additionally, these findings demonstrate that high selective pressure exists
during replication which drives the complete reversion of the CRE(2C) to wt sequence,
from which we propose that it has functions other than the experimentally defined VPg
uridylylation template.
A final, unrelated finding of this dissertation shows that creatinine-hydrochloride
effectively suppresses bacterial growth while allowing outgrowth of slower growing fungi.
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Chapter 1

Introduction

The human enteroviruses (HEV) are a diverse genus in the picornavirus family
(Picornaviridae). The HEV have a variety of pathogenic members including the
polioviruses, human rhinoviruses, and coxsackieviruses (3). The coxsackie B viruses
have six serotypes (3) [CVB1-6] and cause, or have been etiologically linked to, a variety
of important human diseases ranging from type I diabetes to myocarditis, among others
(4-8). Extensive work has demonstrated that the CVB are able to persist after the acute
phase of infection within the tissues of naturally infected humans or mice (9-12) and
within experimentally inoculated primary cells (10, 13) through a mechanism in which
sequence is deleted from the 5’ end of the viral genome (termed CVB-TDs). As further
discussed in chapter 2, these deletions cause loss of much of an important cis-acting
replication element (CRE), termed the cloverleaf or (domain I), leading to an inefficient
form of persistent replication in which both positive and negative strand are
encapsidated (10), a phenomenon never observed in the wildtype (wt) virus. This work
also showed that the CVB-TD still had VPg, the viral protein primer, attached to the 5’
end of the viral genome though rarely terminating in the canonical UU donated by
uridylylated VPg during initiation of replication (10).
The uridylylation of VPg (i.e., the covalent linkage of two uridylic acid residues to
the third amino-acid residue (Y3) in the VPg amino acid chain), also discussed in chapter
2, is mediated by the viral RNA-dependent-RNA polymerase (RdRp) and is templated on
another important viral CRE (14-16), the location of which varies depending on the
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picornaviral genome (16-23). This CRE in the species B HEV (HEV-B) is located within
the 2C protein coding region of the genome (24) and so is termed CRE(2C). The CREs
of the picornaviruses are RNA stem-loop secondary structures which function
independently of the protein coding capacity of the region in which they are found (19,
22, 23). Discussed in detail in chapter 2, extensive work has demonstrated that
mutational disruption of the sequence of either the stem or loop of the CRE(2C) leads to
negative effects on VPg uridylylation and viral replication (24-29) and in general has
been considered lethal. The findings of previous work from our laboratory characterizing
the CVB-TD, showed CVB-TD strains packaged negative strand at a near 1:1 ratio
compared to positive strand and rarely terminate in the canonical UU donated by VPg
during initiation of replication though still having VPg attached to the 5’ genomic terminus
(10). These findings led to the hypothesis that CVB-TD populations did not require a
functional CRE(2C) for replication. In testing this hypothesis, the 16 mutations
previously published (24) were introduced into both CVB3-TD50 and our wt strain CVB328 [(30), termed CVB3-CKO] as described in chapter 2. Surprisingly, our preliminary
studies showed that CVB3-CKO was replication competent in the absence of cytopathic
effect (CPE). This novel finding led to the studies described in chapters 2 and 3 of this
dissertation.
The findings discussed in chapter 2 of this dissertation show that CVB3-CKO is
able to replicate without a functionally (i.e., uridylylating) intact CRE(2C) in both HeLa
cell culture and within mice following electroporation or transfection of viral RNA,
respectively. Whereas wildtype CVB3 replicates efficiently, producing CPE within 48-72
hours (post electroporation of T7 transcribed RNA), and produces encapsidated positive
strand on the order of 108 copies per milligram (wet weight) of HeLa cells (chapter 2),
this is not the case when the CRE(2C) is mutationally disrupted. Indeed, CVB3-CKO
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was found to replicate to a titer nearly 100,000 fold lower than that observed with wt, and
produced no detectable CPE eight days after electroporation of HeLa cells (chapter 2).
Similar findings were observed with both CVB3-TD50 and CVB3-TD50-CKO. Another
novel finding reported in chapter 2 was that a population of viruses with 5’ TDs evolved
in CVB3-CKO after eight days post electroporation. This was an important finding that
suggested that without an intact CRE(2C), CVB3-CKO initiates replication in a manner
similar to that of the TD viruses discussed in chapter 2 and previously characterized
(10). After characterizing the replication of CVB3-CKO, it was important to determine if
the mutations introduced into the CRE(2C) region remained intact at various times
leading up to the final day eight time-point. This was an important aspect of the work
because it was hypothesized that reversions would occur within the CRE(2C) of CVB3CKO after several rounds of replication.
As further discussed in chapter 3 of this dissertation, RNA viruses exist as
heterogeneous populations, or quasispecies (31-33). As a whole, the RNA viruses are
capable of rapid evolution due the highly error-prone nature of their RdRp (34-36) and
through recombination of viral genomes (37-40). In addition to allowing for evolution and
rapid selection of the fittest viral genomes in a given environment (33), these attributes
also allow RNA viruses to rapidly revert mutated sequences which may be detrimental in
a given environment; i.e., mutations that would subsequently inhibit aspects of their
replication or dissemination (41-44). This may be precisely the case when the CRE(2C)
of CVB3 is mutationally altered. As discussed above and in chapter 2, others
considered mutational disruption of the CRE(2C) of either poliovirus or CVB3 to be lethal
(24, 45). However, the work presented in this dissertation indicates this is not the case,
at least for CVB3. Indeed, not only has this work demonstrated that disruption of the
CRE(2C) is not lethal for CVB3 (chapter 2), the results presented in chapter 3 of this
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dissertation significantly extend these results and shows the novel finding that the 16
introduced mutations [(24); chapter 2] in the CRE(2C) revert completely to that of the wt
sequence in the majority population, with this occurring after as few as eight days of
replication in HeLa cells. This suggests that while loss of a functional CRE(2C) is not
lethal to the virus, a high selective pressure exists which drives complete reversion to a
wt CRE(2C) sequence. The data presented in chapter 3 also demonstrate that evolution
of 5’ TDs occurs prior to reversion of the CRE(2C). If this were not the case, and the
CRE(2C) reverted without the evolution of 5’ TDs, the presence of CPE would be
expected because a cytopathic virus has both the intact 5’ genomic terminus and an
intact CRE(2C). This, however, was not observed. Together, these results are
consistent with the CRE(2C) having another, as yet undefined, function(s) besides
providing a framework and template for VPg uridylylation, and that the structure of the
CRE(2C) is more important for viral replication than is most of domain I.
To provide education and a skill set outside of the field of virology, chapter 4,
although unrelated to the work presented in chapters 2 and 3 of this dissertation,
describes another novel exploration in the field of microbiology:

the characterization of

a small molecule that functions as an antibacterial, creatinine hydrochloride (CRN-HCl).
Creatinine (CRN) is a vertebrate metabolic waste product normally found in blood and
urine (46), the formation of which is further described in chapter 4. Previous work
demonstrated the hydrochloride salt of creatinine, CRN-HCl, can be a potent inhibitor of
bacterial replication (47). Interestingly, it was apparent that CRN-HCl did not inhibit the
growth of yeasts or molds (i.e. fungi), making it a potentially useful addition to growth
media to facilitate isolation of environmental or clinically relevant fungal species (47). In
general and as elaborated on in chapter 4 of this dissertation, Sabouraud dextrose agar
(SDA) is the current medium of choice for the detection and isolation of fungi, although it
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does not offer optimal nutritional requirements for some fungi and can permit growth of
bacteria which may subsequently inhibit fungal growth and/or obscure fungal isolation
(48-54). The work presented in chapter 4 of this dissertation demonstrates a significant
improvement for the process of identifying fungi by showing that CRN-HCl effectively
suppresses bacterial growth in either liquid or solid agar media while allowing outgrowth
of (slower growing) fungi from either experimentally prepared samples or environmental
samples and that it can be used in addition to, or in lieu of, SDA.
Taken together, the data presented in this dissertation have important
implications, not only for the field of virology but for microbiology as a whole. The results
presented in chapters 2 and 3 change the way initiation of replication of the CVB, and
perhaps the HEV, must be viewed, so forcing a re-examination of the currently
understood HEV RNA replication mechanism. Further, these chapters offer a novel
insight into how HEV may have replicated and evolved from more primitive forms.
Chapter 4, while not related to the virology of chapters 2 and 3, further supports the
antibacterial activity of a small molecule, creatinine, once considered to have no
biological activity, and highlights its potential use in the clinical/research laboratory.
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Chapter 2

Mutational disruption of the CRE(2C) in coxsackievirus B3 leads to 5’ terminal
genomic deletions 1.

Introduction

Group B Coxsackieviruses (CVB, serotypes 1-6) are non-enveloped, singlestranded, positive sense RNA viruses classified as human enteroviruses (HEV), species
B, within the viral family Picornaviridae (55). The CVB cause, or are etiologically
associated with, a variety of human diseases including aseptic meningitis, myocarditis,
pancreatitis, and type I diabetes (4-8). The small, single stranded, positive sense HEV
RNA genome encodes 11 proteins from a single open reading frame (ORF). Upon
successful viral infection of the host cell, the HEV genome is translated and then
functions as a template for the synthesis of a negative-sense RNA strand, which serves
in turn as the template for the replication of the positive-stranded genomic RNA (55-57).
Four cis-acting replication elements (CRE) which modulate replication and
translation have been identified in the HEV genome; these are at the 5’ and 3' termini of
the genomic positive strand, within the open reading from (ORF) of the positive strand,
and at the 3’ end of the negative RNA strand (a replicative intermediate) (17, 58). The 5’
and 3’ ends of the genomic RNA are non-translated regions (5’ NTR and 3’ NTR), the
latter of which terminates in a poly-A tail. A clover-leaf secondary structure termed
domain I (Fig 1A), is present at the 5’ terminus of the HEV genome (59, 60) and is
believed to be the site of
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FIG. 1. Domain I and the CRE(2C) of CVB3 and the location of protein binding to these
structures. (A) Domain I of CVB3 located at the 5’ terminus of the genome (grey nucleotides
indicate deleted sequence in CVB3-TD50). (B) The CRE(2C) of CVB3 located in the 2C protein
coding region from nucleotides 4365-4425. The three red adenines at the apex of the loop
represent the experimentally determined template for the uridylylation of VPg (C) During
replication of the CVB3 genome, viral protein 3CD and host-cell protein poly(rC) binding protein
2 (PCBP2) bind in the region of domain I and viral proteins 3CD and 3Dpol bind to the CRE(2C)
to mediate the uridylylation of VPg.
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formation of the replication complex which includes both viral and host cell proteins
required for negative strand synthesis (25, 60-64). Binding of the viral protein 3CDpro to
stem-loop d of domain I and the host cell protein poly(rC)-binding protein 2 (PCBP2) to
stem-loop b of domain I (or the poly-C tract in the spacer region between domain I and
domain II of the internal ribosome entry site [IRES]) (Fig 1C), has been proposed to be
required for negative strand synthesis (65-69). It has been demonstrated using a cellfree system that deletion of 4 nucleotides from stem-loop d of poliovirus RNA led to a
loss of both negative strand synthesis and production of viral proteins (25), perhaps due
to decreased, or loss of, binding of 3CDpro. Further studies demonstrated that, with
domain I left intact, deletion of portions or all of the internal ribosome entry site (IRES)
from poliovirus RNA did not affect the synthesis of either negative or positive genomic
RNA in a cell-free system (70). These findings indicated that domain I, but not the IRES,
of the 5’NTR was crucial for efficient replication of the viral RNA.
Our previous work identified a mechanism of CVB persistence in which domain I
can largely be lost during replication in experimentally-inoculated cell cultures and mice
(10, 13), as well as within heart tissue of naturally infected humans (9); more recent
evidence suggests that HEV evolve 5' TD populations in cardiomyopathic human heart
tissues at the terminal stage of disease (12) as well as within the pancreatic tissue of
experimentally inoculated mice (11). The discovery of naturally-occurring enteroviral 5’
terminal deletions (TD) modified our understanding of enteroviral biology not only by
demonstrating that enteroviruses without an intact domain I were viable but that 5' CVBTD populations replicated with a severe deficiency in positive strand RNA replication.
This was readily apparent in the reduction of positive to negative strand viral RNA ratios
to near unity in CVB-TD infected cells as well as by the demonstration of efficient
encapsidation of the replication incompetent negative strand (10). The inefficient
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replication observed with CVB-TD viruses (10, 13) confirmed and significantly extended
the well-established role of domain I as contributing to efficient viral replication and
positive-strand RNA synthesis (58, 60, 71). With much of domain I lost in TD viral RNA
populations (Fig 1A), it is not surprising that CVB-TD strains replicate to low titers not
detectable by standard cell culture assays using cytopathic effect (CPE), but require
detection via enzymatic amplification. Further work by Sharma and colleagues
demonstrated that CVB-TD viral genomic RNA was stable and replication competent
with up to 49 nucleotides deleted from the 5’ terminus, although at a minimal level in a
cell free reporter system (69), supporting and extending our previous findings.
Curiously, while we observed that CVB-TD genomes rarely terminated in the canonical
UU derived from the uridylylated VPg primer during positive strand synthesis (9, 10, 13),
VPg was still linked to the 5’ end of the TD genome (10).
In addition to the 3’ and 5’ NTR CREs, picornaviruses also possess small hairpin
structures within the genome necessary for efficient RNA replication which template the
uridylylation of the viral protein primer VPg (14, 24, 72); VPg is subsequently used as the
RNA replication primer. These hairpin structures are located at different sites within
various picornaviral genomes (16-23) with that of the enterovirus genus (except
rhinoviruses) located in the 2C coding region [CRE(2C) Fig 1B] (24). It has been firmly
demonstrated that these CRE are location- independent (19, 22, 23): for example,
poliovirus remains replication competent when the CRE(2C) is moved from the 2C
protein coding region of the ORF to the 5’ NTR (26). Despite diverse locations of
picornaviral CREs, the location within a species is highly conserved (17). To determine
the function and structural requirements of the HEV CRE(2C), both cell culture and cell
free systems have been used to analyze the effects of mutations introduced into the
CRE(2C) region. These studies defined the site of the template nucleotides for the
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addition of uridine residues to VPg [in the loop of the predicted RNA structure (14, 73)],
and defined the degree to which uridylylation and replication are disrupted by mutations
in the loop or stem of the structure (24-29). Studies of replication in cell culture not only
demonstrated a loss of CPE upon transfection of some poliovirus (PV) CRE(2C) mutants
but also demonstrated that some mutants were capable of a dominant-negative effect
(74): replication of wt PV within the same cell was inhibited by the presence of these
single site mutations. But this effect is not complete: in the cell free system, perhaps
because of the non-compartmentalized nature of the replication, low level replication is
observed in the mutated CRE(2C) genomes as evidenced by the presence of replicative
form intermediate production and, unlike in cell culture assays, CRE(2C) mutations could
be rescued in trans (75). In addition, passage of some initially non-cytopathic mutants
(following transfection of T7 transcribed RNA) resulted in CPE, demonstrating that
although the CRE(2C) mutations had a severely debilitating effect on virus replication,
sufficient replication of the viruses had occurred permitting reversion to restore the wt
sequence (19). Analysis of CRE(2C) mutations in cell free systems allows for
quantitative assays of replication based on incorporation of radioactive nucleotides and
demonstration of effects upon the generation of uridylylated VPg (24, 27, 29, 45, 75).
The greatest effect upon uridylylation was noted in mutations of the A5 and A6
nucleotides of the loop (Fig. 1B; red nucleotides) but considerable defects of
uridylylation and RNA replication in the cell free assays were observed with mutations in
the stem or loop region (24, 45, 75). When 16 silent mutations were introduced into the
CVB3 CRE(2C), creating the CRE(2C)-DM mutant (31), the virus was deemed unable to
replicate based upon failure to detect both uridylylated VPg and positive strand synthesis
and an inability to detect virus-expressed luciferase activity above background levels 10
hours after transfection of cell cultures.
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Our findings (9, 10) that CVB3-TD strains replicated poorly compared to wt and
that VPg was attached to CVB3 genomic termini despite a general lack of the 5'-UU
consensus sequence, suggested the possibility that VPg was being non-specifically
nucleotidylated, or nucleotidylated in-situ, instead of specifically uridylylated, in order to
function as the primer for viral RNA replication. We therefore hypothesized that a
functional (uridylylating) CRE(2C) would not be required for replication of TD viruses.
Using the same 16 mutations described for the CRE(2C)-DM mutant (24), we generated
the wt CVB3 genome with these mutations (termed here CVB3-CKO for CRE knockout)
to serve as a replication control for studies of CVB3-TD replication; we also generated
the CKO mutations in the CVB3-TD50 infectious cDNA clone (CVB3-TD50-CKO).
Indeed, a non-functional CRE(2C) was not necessary for CVB3-TD50 replication but
contrary to expectations, we also observed that CVB3-CKO was viable. In this report,
we demonstrate that in cell culture or in mice, this specific disruption of CRE(2C) in
CVB3, while detrimental to viral replication, is not lethal after all. Further, we
demonstrate that when the native structure of CRE(2C) is altered in this way in a nonterminally deleted genome, the virus population rapidly evolves to become populations
containing 5’ terminal genomic deletions.

Materials and Methods

Cells and viruses. Coxsackievirus B3, strain 28 (30), was used in this work as the
wildtype (wt) strain. HeLa cell monolayer cultures were maintained in Dulbecco’s
Modified Eagle Medium (DMEM/High Glucose [GE Life Sciences, Logan, UT,])
containing 10% newborn calf serum and 50 μg/mL gentamicin (GIBCO, Life
Technologies, Grand Island, NY). Viral stocks were prepared in HeLa cells by
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electroporation of 2x10⁶ cells at 100V and 1,980 μF (Cell-PORATOR, GIBCO, Life
Technologies) with 12 μg of viral RNA (equivalent to 2.96x10¹² genomes) transcribed
from infectious cDNA clones of either wt CVB3, CVB3 in which CRE(2C) was
mutationally disrupted with 16 mutations [(CVB3-CKO) as described below in mutational
disruption of the CRE(2C) using overlap extension PCR], CVB3 with a 49 nucleotide 5'
terminal deletion [CVB3-TD50; (10)] , and CVB3-TD50 in which the CRE(2C) was
mutationally disrupted (CVB3-TD50-CKO). Cells were subsequently seeded into
100mm dishes. After eight days of incubation, with replacement of medium at day four,
cultures were examined for cytopathic effect (CPE) using an Olympus CKX41 inverted
microscope with a DP12 camera; complete CPE was observed with wt at 2 days post
electroporation. After freezing and thawing three times, the lysates were cleared of cell
debris by centrifugation at 30,000 RPM for 30 min at 8oC (SW28.1 rotor; Beckman, Brea,
CA) and then prepared as described previously (10). This preparation was termed pass
1 as previously described (10).

Mutational disruption of the CRE(2C) using overlap extension PCR. The mutations
in the CVB3 CRE(2C) were generated using overlap extension mutagenesis (76). Two
overlapping fragments of CVB3 cDNA were generated by PCR from the infectious cDNA
clone of CVB3/28 (30) using Deep Vent DNA polymerase (New England Biolabs;
Ipswich, MA) and the primer pairs ID13 and CREKORev or CREKO and XBA (Table 1)
with 4 mM MgSO4 and 200 µM dNTPs. Cycling was carried out as noted (Table 2) with
modified cycle denaturation and annealing times of 30 sec each. The two amplimers
were gel purified, combined in Thermopol reaction buffer (20mM Tris-HCl, 10mM
(NH4)2SO4, 10 mM KCl, 4 mM MgSO4,0.1% Triton® X-100 pH 8.8; New England
Biolabs) with 200 µM dNTPs and repeatedly denatured and annealed 10 times

Table 1. Names, annealing sites, and sequences of primers used in CKO studies.
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Table 2. Standard PCR cycle parameters and primer pair variations.
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(1 minute at 94oC / 50oC for 1 minute) followed by extension with Deep Vent polymerase
(2,000 u/mL) at 72oC for 2 minutes. The mutated overlap extension product was
subsequently directly amplified using the ID13 and XBA primers (Table 1; 2) and Deep
Vent polymerase with the modified denaturation and annealing times as described
above. The amplified product of this reaction was digested with BssH2 and XbaI, then
ligated with the BssH2-XbaI restriction fragment of pCVB3 or pCVB3-TD50 (10) to
produce pCVB3-CKO and pCVB3-TD50-CKO.

Preparation of T7 RNA transcripts for electroporation or transfection. Preparation
of infectious cDNA copies of CVB3 and CVB3-TD50 genomes was described previously
(10). Mutational disruption of the CRE(2C) region of these clones to generate CVB3CKO and CVB3-TD50-CKO is described above in mutational disruption of the CRE(2C)
using overlap extension PCR. Viral RNA was transcribed from 5 µg of ClaI-linearized
cloned cDNA using the T7 RiboMAX System (Promega; Madison, WI) for one hour
followed by removal of the DNA template by digestion with RQ1 DNAse (6 units). RNA
was precipitated overnight at -20°C in 120 μL containing 4mM EDTA, 80 μg of glycogen,
and 2 M LiCl, pelleted and resuspended in RNase-free water. The expected 7.4 kb size
of the viral RNAs was verified on a 1.4% native agarose gel and concentrations were
determined spectrophotometrically.

Cell culture of purified virus stocks (pass 2). CVB3-CKO replicates to very low titers
and does not produce observable CPE. Consequently, inoculation of cell cultures with
both CVB3-CKO and wt CVB3 virions was performed as described previously (10) using
virus titers based upon positive strand RNA concentration copy number in the virus

16
preparations which were derived from reverse transcription quantitative PCR (RT-qPCR)
analyses (see titering viral RNA in purified virus stocks using RT-qPCR below). Thus,
for passage of purified virions in HeLa cell cultures, 3x105 HeLa cells (80-90% confluent)
per well in 24-well plates were inoculated in duplicate with the equivalent of 3,190
positive RNA genomic strands. In addition, equivalent amounts of virus were incubated
for 1 hour at 37oC with a 1:400 dilution of anti-CVB3 neutralizing antibody (ATCC;
Manassas VA) prior to inoculation of cells. Plates inoculated in the presence of
neutralizing antibody were incubated for 3 hours at 37°C, the monolayers were washed
twice with phosphate buffered saline (PBS), then provided fresh medium and incubated
with neutralizing antibody for 5 days. Plates inoculated without antibody were incubated
overnight at 37°C prior to washing. The cells were harvested by direct TRizol lysis in the
wells, followed by RNA isolation per manufacturer’s protocol, isopropanol precipitation
with glycogen as a carrier (77), and resuspended in nuclease free water. Total RNA was
assayed for the presence of CVB3 RNA using nested RT-PCR as described below.

Transfection of mice and detection of viral RNA in tissue homogenates using RTPCR. The use of mice in this study was approved by the University of Nebraska Medical
Center Institutional Animal Care and Use Committee. Male A/J mice (6-7 weeks old;
Jackson Laboratories, Bar Harbor, ME) were inoculated intraperitoneally (i.p.) with 25 μg
(equivalent to 6.2x10¹² genomes) of CVB3 or CVB3-CKO T7 transcripts (prepared as
described in preparation of T7 RNA transcripts for electroporation or transfection above).
Inocula (0.1 mL/mouse) were prepared in 0.4 mL aliquots containing 100 μg T7
transcribed RNA in 100 μL of nuclease free water, 100 μL of LIPID-based In Vivo
Transfection Reagent (Altogen Biosystems, Las Vegas, NV), 20 μL transfection
enhancer, and 80 μL of a 5% (w/v) sterile glucose solution. Hearts and spleens from
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mice at 5 and 8 days post-transfection (wt CVB3) or 20 days post-transfection (CVB3CKO and saline transfection control) were split into two approximately equal portions
and one half weighed, then tissue was homogenized in 500 μL TRizol (Invitrogen;
Carlsbad, CA) and total RNA was extracted as described in cell culture of purified virus
stocks above. To detect viral RNA, a series of four 10-fold dilutions were prepared to
find optimal RNA concentration for reverse transcription. This method was required for
all RNA preparations from mouse tissue, as the required dilution varied between 100
and 1,000 fold depending on the tissue and mouse. cDNA was then transcribed from
each dilution with primer E3 (Table 1) at a final concentration of 2 μM. Briefly, RNA was
denatured for 5 min at 70oC and incubated for 2 min on ice. RNA was then reverse
transcribed using the ImpromII reverse transcriptase system (Promega) with 0.8 mM
dNTPs, 2 mM MgCl2, and 1 µl enzyme (the number of units are proprietary and not
provided by Promega) in 20 µl reaction buffer for 60 minutes at 42°C. cDNA was
ethanol precipitated as before, resuspended in water, and nested RT-PCR for viral RNA
detection was performed as described below.

Inoculation of cell cultures with spleen homogenates. Murine spleen was
homogenized in complete tissue culture medium, frozen and thawed 3 times, then
centrifugally cleared at 16,000 x g for 10 min. These cleared homogenates were then
treated with RNase A as described in cell culture of virus stocks above. Duplicate HeLa
cell cultures (as described above) were inoculated with 100 μL of cleared, RNased
splenic homogenate from CVB3-CKO transfected mice (20 days post-transfection) or 1
μL of splenic homogenate from wt CVB3 transfected mice (8 days post transfection; the
lower volume for wt CVB3 was chosen based on the higher extent of replication in cell
culture observed for wt CVB3 by RT-qPCR). Cell cultures were inoculated in the

18
presence or absence of a 1:400 dilution of anti-CVB3 neutralizing antibody; preparations
containing neutralizing antibody were treated as described in cell culture of virus stocks
above. After 3 hours of incubation (plates containing antibody) or overnight incubation
(plates without antibody), cultures were washed 2 times with PBS and media was
replaced with the presence or absence of neutralizing antibody. Cultures were observed
daily by light microscopy for CPE. After 5 days, total RNA was extracted from each
monolayer as described in cell culture of purified virus stocks above. RNA preparations
were then assayed for viral RNA using nested RT-PCR (see “nested RT-PCR to detect
viral RNA” below).

Detection of positive strand viral RNA in purified pass 1 virus preparations. Total
RNA was isolated from purified virus preparations using TRizol as described in cell
culture of purified virus stocks above, and cDNA was prepared (described above) using
a tagged (78) antisense primer, PinE3 (Table 1), designed using a non-CVB3 specific
oligo tag (Pin) 5’ of nucleotides corresponding to a region of the 5’ NTR that has not
been found to delete (Table 1). Half of each cDNA reaction was amplified using the
primers S5 and the tag primer Pin (Table 1) in GoTaq Green Master Mix (Promega).
Reactions were cycled as noted for primer pairs (Table 2) followed by electrophoresis on
2% agarose gels for analysis.

Enzymatic amplification of the CRE(2C) sequence from plasmids and T7
transcripts. The CRE(2C) region of wt CVB3 and CVB3-CKO plasmids, and cDNA of
T7 transcripts of cloned cDNA, was amplified using nested primers in 20 μL reaction
volumes containing GoTaq Green Master Mix (Promega). The primers for the first
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enzymatic amplification were 4523Rev and 2B1 (Table 1; 2) at a final concentration of
0.5 μM. After ethanol precipitation, a second round of PCR was carried out with the
ethanol precipitated amplimers using primers 2C2 and 2C7 (Table 1; 2). PCR reactions
were electrophoresed on 2% agarose gels and bands at the appropriate size (Table 2)
were excised and purified using the Zymoclean Gel DNA Recovery Kit (Zymo Research;
Irvine, CA) per manufacturer’s protocol. Recovered amplimers were sequenced with
primer 2C7 (Table 1) to verify that sequences were either wt (CVB3) or CRE(2C)
mutants (CVB3-CKO) as expected prior to electroporation and virus preparation.

Nested RT-PCR for detection of viral RNA in total RNA isolated from cell culture
lysates and mouse tissues. To test for viral RNA presence in cell culture or mouse
tissue, nested RT-PCR was performed to detect the 5' NTR sequence in the CVB3
genome corresponding to nucleotides 45-564. Initial enzymatic amplification of all cDNA
samples from viral RNA preparations (except for initial viral RNA detection in sucrose
purified preparations; described in detection of positive strand viral RNA in purified pass
1 virus preparations above) was carried out using primers S4 and E3Sub (Table 1; 2) in
GoTaq Green Master Mix (Promega). A second round of PCR was carried out using the
ethanol precipitated product of the S4-E3Sub PCR amplification with S5 and SReturn
(Table 1; 2). Final PCR products were analyzed on gels as described for “detection of
viral RNA from purified virus preparations” above.

Titering viral RNA in purified virus stocks using RT-qPCR. Because CVB3-CKO,
CVB3-TD50, and CVB3-TD50-CKO viruses do not produce detectable CPE upon
infection of tissue culture monolayers, viral RNA copy number was quantitated using RT-
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qPCR similar to that described previously (10). cDNA was transcribed using Improm II
Reverse Transcriptase (Promega) and primer E3 (Table 1) as described in “transfection
of mice and detection of viral RNA in tissue homogenates using RT-PCR” above. RTqPCR was performed using an Opticon 2 DNA Engine (MJ Research; Waltham, MA) by
combining cDNA reactions with primers E2 and E3Sub (Table 1) in Maxima SYBR
Green/Fluorescein qPCR master mix (2X; Thermo Scientific, Waltham, MA). qPCR
cycling was carried out as indicated for primer pairs (Table 2) with a modified annealing
time of 10 sec. Standard curves were generated with 10 fold serial dilutions of a 500bp
amplimer of CVB3 cDNA generated with primers S and E3 (Table 1); amplimer was at a
known concentration previously calculated using spectrophotometry. Knowing the cDNA
copy number generated from an RT reaction containing a specific amount of RNA, the
efficiency of the cDNA transcription (molecules of cDNA/molecules of RNA) was
calculated. Statistical analysis was carried out with GraphPad Prism software using
one-way ANOVA with Bonferroni correction.

RT-PCR to detect 5’ terminal deletions in purified virus stocks. cDNA from purified
virion preparations was prepared using Improm II reverse transcriptase (Promega) and
primer E3 (Table 1) as described in “transfection of mice and detection of viral RNA in
tissue homogenates using RT-PCR” above. All reverse transcriptase reactions were
assembled with an equal RNA copy number for comparison of presence of 5’ terminal
sequences. Copy numbers were calculated using either cDNA copy number determined
by RT-qPCR (for virus preparations) or were calculated based on RNA concentration
from spectrophotometric analysis (for T7 transcribed RNA controls). Tagged primers
[(78) and detection of positive strand viral RNA in purified pass 1 virus preparations
above] corresponding to regions of the 5’ genomic terminus were used to detect 5’
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terminal deletions. Initial enzymatic amplification was carried out using Pin5End1 and
E3 (Table 1; 2) and 400 copies of E3 cDNA or Pin5End5 and E3 (Table 1; 2) with 1,400
copies (at the experimentally determined limit of detection for the respective primer
pairs), in GoTaq Green Master Mix (Promega) with a modified annealing time of 10 sec.
PCR products were ethanol precipitated. The second round of enzymatic amplification
was performed with the first ethanol precipitated reaction product in GoTaq Green
Master Mix with Pin and SReturn (Table 1; 2). PCR products were analyzed on
agarose gels as described in “detection of positive strand viral RNA” above.

Results

CVB3-CKO replicates in HeLa cells. The HEV CRE(2C) is required for efficient viral
replication (24, 29, 45, 75) and it is established that various mutational disruptions of the
CRE(2C) in either poliovirus or CVB3 are lethal based on the absence of radiographic
evidence for positive strand (genomic) RNA replication, VPg uridylylation (24, 29, 45), or
luciferase activity after 10 hours of incubation in cell culture (24). Our previous findings
demonstrated that a CVB-TD genome rarely terminated in the canonical UU donated by
uridylylated VPg upon replication, yet still had VPg linked to the genomic RNA (79).
Therefore, we hypothesized that CVB-TD would not require a functional (that is to say,
uridylylating) CRE(2C) in order to successfully replicate. To test this, we introduced the
previously characterized 16 mutations [described as CVB3-CRE(2C)-DM; (24)] in both
the wt CVB3 (initially intended as a negative control) and CVB3-TD50 infectious cDNA
clones; the sequences of the CRE(2C) region in the DNA clones and in the T7
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FIG. 2. Virus without a functional CRE(2C) can be recovered in the absence of
observable CPE following electroporation of HeLa cells with T7 RNA transcripts from
infectious cloned genomes. (A) CVB3-CKO does not produce observable CPE at eight
days post electroporation with 18 μg of RNA compared to the tissue culture control (TCC)
electroporated with saline only. Wt CVB3 RNA induced complete CPE by 48 hours post
electroporation. Images at 100x original magnification. (B) Quantitation of viral RNA in
RNase treated and sucrose purified mutant virus preps (CVB3-CKO; CVB3-TD50, or CVB3TD50-CKO). Loss of CRE(2C) function, deletion of 49 nucleotides from the 5’ terminus in
domain I, or both, does not lead to a lethal virus phenotype but deleteriously affects
replication when compared to wt CVB3. Loss of CRE(2C) in CVB3-CKO lowers extent of
replication to a level similar to that of CVB3-TD50, but loss of CRE(2C) in CVB3-TD50
(CVB3-TD50-CKO) does not further impact replication.
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transcripts from the clones (after cDNA synthesis) were verified prior to use as described
in methods.
HeLa cells were electroporated with equivalent copy numbers of full-length wt
CVB3, CVB3-CKO, CVB3-TD50, or CVB3-TD50-CKO T7 transcribed RNA, then cultured
for 8 days. As expected from others' work (24), no CPE was observed in the CVB3-CKO
electroporated monolayers (Fig. 2A, CVB3-CKO) when compared to the electroporation
control cells (Fig. 2A, TCC), nor was CPE evident in cultures transfected with any of the
other viral RNAs (data not shown) except wt CVB3 which completely lysed the culture by
48 hours post-electroporation (Fig. 2A, wt CVB3). The observed absence of CPE in
cells electroporated with CVB3-CKO was consistent with studies indicating that a
mutated CRE(2C) suppresses or ablates viral replication (24, 27, 45, 75).
However, because our previous work had demonstrated that CVB3-TD strains
also showed no apparent CPE in cell cultures yet could be shown to be replicating using
RT-PCR to detect viral RNA (10, 13), we also assayed all electroporated cultures for the
presence of encapsidated CVB3 RNA. Viral RNA was extracted from concentrated,
RNased virion preparations for the detection of viral RNA in pass 1 preparations. To
determine whether and to what extent CVB3-CKO and CVB3-TD50-CKO were
replicating (compared to wild-type CVB3 or CVB3-TD50), viral RNA was extracted from
aliquots of the RNase treated and pelleted preparations and RT-qPCR performed (Fig.
2B). These results (based on five replicate plates and 10 data points [CVB3-CKO and
wt CVB3] or two replicate plates and four quantitative data points [CVB3-TD50 and
CVB3-TD50-CKO]) indicated that CVB3-CKO was indeed replication competent as the
RNA was derived from pelleted viral particles. CVB3-CKO replicated to approximately
five logs lower than wt CVB3 (Fig. 2B, compare CVB3-28 [wt] to CVB3-CKO),
indicating that ablation of the CRE(2C) uridylylation function severely handicaps
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replication of the parental virus. Interestingly, these results also showed that there is no
significant difference in the extents of replication of CVB3-CKO compared to CVB3TD50, and that the mutational disruption of the CRE(2C) in a CVB3-TD virus does not
significantly alter its replication (Fig. 2B, compare CVB3-CKO to CVB3-TD50-CKO and
CVB3-TD50). In summary, the ablation of CRE(2C) function is not lethal in either wt
CVB3 or in a CVB3-TD strain but it does lower the level of replication to the level of
CVB3-TD populations. Important to note is that the CVB3-TD50-CKO strain did not
replicate at a lower level than either CVB3-CKO or CVB3-TD50, indicating that the
functional loss of the two CREs [domain I and CRE(2C)] is not additive.

Replication of CVB3-CKO is accompanied by generation of 5’ terminally deleted
CVB3-CKO genomes. Because the replication of CVB3-CKO and CVB3-TD50 are
similarly poor (i.e,. apparent absence of CPE and replication on the order of five logs
lower than wt CVB3) and mutational disruption of the CRE(2C) does not affect overall
replication of the CVB3-TD50-CKO strain more than that observed for CVB3-TD50, we
hypothesized that alterations at either of these sites were likely to result in the same type
of positive strand initiation and, consequently, 5' terminal genomic deletions could be
occurring during the replication of CVB3-CKO in cell culture. We therefore used RTPCR to test whether 5' terminal deletions had arisen in the CVB3-CKO population.
Using equivalent numbers of positive sense viral RNA strands for wt CVB3 and CVB3CKO, cDNA was transcribed using E3 primer (Table 1) followed by PCR using primers
designed to detect sequences close to the 5’ terminus (Fig. 3A-C). Absence of banding
in the CVB3-CKO amplifications correlating to the 5’ terminal 20 nucleotides (Fig. 3D,
arrows, lanes 2 and 3) compared to wild-type CVB3 viral RNA (Fig. 3C, lanes 5 and 6)
and controls (Fig. 3C, lanes 8-9, 11-12) indicated that the CVB3-CKO viral RNA had lost
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FIG. 3. Loss of a functional CRE(2C) leads to evolution of 5’ terminal deletions in
CVB3-CKO after 8 days of replication in HeLa cells. (A) A schematic of how
amplification with PIN primers works. (B-C) Relative position in the CVB3 genome of
tagged primers used to amplify 5’ terminal sequence (B) or to amplify sequence in the 5’
NTR in a region where deletions do not occur (C). (D) Agarose gel analysis of E3 primed
cDNA amplified with primers Pin5End1 and E3 or Pin5End5 and E3, then subsequently
amplified with primers Pin and SReturn (lanes 2-3, CVB3-CKO purified virus preparation;
lanes 5-6, CVB3-CKO T7 transcripts; lanes 8-9, wt CVB3 virus preparation; lanes 11-12,
wt CVB3 T7 transcripts). To detect virus using a region of the 5’ NTR that has not been
found to delete, cDNA was made with primer PinE3 and amplified with primers S5 and
Pin (lane 4, CVB3-CKO virus preparation; lane 7, CVB3-CKO T7 transcripts; lane 10, wt
CVB3 virus preparations; lane 13, wt CVB3 T7 transcripts). 400 (Pin5End1) or 1,400
(Pin5End5) copies of cDNA prepared from purified viral RNA or T7 transcribed RNA
(controls) were used in each PCR reaction. Arrows indicate the loss of sequence from
the 5’ terminus of CVB3-CKO (lanes 2 and 3) as compared to T7 or wt virus controls
(lanes 5-6; 8-9; 11-12). However, CVB3-CKO virus could be detected by RT-PCR
priming in a region of the 5’ NTR that has not been found to delete (compare lane 4 to
lanes 7; 10; and 13). (E) Controls (lanes 2-4, no cDNA PCR controls, lanes 5-7 no
template RT-PCR controls, lanes 8-10 tissue culture controls) were negative.
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5’ terminal sequence. Water (no cDNA), no template RT-PCR, and tissue culture
controls were all negative (Fig. 3E, lanes 2-4 no cDNA PCR controls, lanes 5-7 no
template RT-PCR controls, lanes 8-10 tissue culture controls). However, bands
were observed from cDNA amplified from both CVB3-CKO and wt CVB3 with primers
that correlate to sequence in the 5’ NTR of the genome (Fig. 3C) greater than 50
nucleotides downstream of the 5’ terminus (Fig. 3D, lane 4 [CVB3-CKO] and 7 [wt
CVB3]) demonstrating that virus was indeed present in the CVB3-CKO preparations.
Thus, the majority population of CVB3-CKO RNA is lacking all or most of nt 1-24 of the
wt CVB3 genome, similar to what was observed in persisting CVBs in human and
murine infections (10, 11, 13).

CVB3-CKO virions can be sequentially passaged in cell culture and productive
infection is neutralized by anti-CVB3 neutralizing serum. Previous work
demonstrated that CVB3-TD viruses encapsidate RNA and could be passaged in cell
culture and neutralized by anti-CVB3 neutralizing antibody (10). Because we had
generated stocks of virions that had been partially purified using RNase A to degrade
non-encapsidated RNA followed by ultracentrifugal pelleting through a 30% sucrose
cushion (Fig 2B), we had evidence that viral RNA was encapsidated and RNA detection
was not due to contamination with free viral RNA. This is in contrast to the previous
observation that mutational disruption of the CRE(2C) in HEV was lethal based on the
absence of CPE in cell culture, single-stranded RNA in autoradiographic assays, and the
absence of luciferase activity after only ten hours of incubation in transfected cells (24,
29, 45). As a further test that CVB3-CKO was producing infectious virions, we used
RNase-treated and ultracentrifugally-collected virus preparations to inoculate fresh cell
cultures (termed pass 2) in the presence or absence of anti-CVB3 neutralizing antibody.
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FIG. 4. CVB3-CKO replicates without observable CPE and can be passaged from
purified HeLa cell lysates and neutralized by anti-CVB3 neutralizing antibody. (A-F)
HeLa cell monolayers at five days post inoculation with wt CVB3 or CVB3-CKO with antiCVB3 neutralizing antibody (A-C) or without antibody (D-E). CVB3-CKO does not
produce CPE after infection. (B) Neutralizing antibody prevents CPE (C) with wt CVB3 at
five days post inoculation (compare to without neutralizing antibody, panel F). Images at
100x original magnification. (G) Nested primers used to amplify sequence in the 5’ NTR
of CVB3 to detect viral RNA post inoculation of cell cultures. Primers are located in a
region of the 5’NTR where deletions do not occur. (H) Total RNA was extracted from
HeLa cells monolayers five days post inoculation and assayed for the presence of viral
RNA by nested PCR and gel electrophoresis. Wt CVB3 was detected (lanes 8 and 9) as
well as the non-cytopathic CVB3-CKO (arrows, lanes 4 and 5). The absence of bands
when neutralizing antibody was present in the cell cultures (CVB3-CKO; lanes 2 and 3; wt
CVB3; lanes 6 and 7) demonstrate that the antibody effectively suppressed productive
infection. (I) Controls (lanes 2-4, no cDNA PCR controls; lanes 5-7, no RNA RT-PCR
controls; lanes 8-10, tissue culture controls) were all negative. (J) Additional virus
preparations were tested to verify observations made in H. CVB3-CKO can be passaged
in cell culture (lane 3) as compared to the T7 RNA transcript control (lane 1) and can be
neutralized with anti-CVB3 neutralizing antibody (lane 2).

28
HeLa cells in 24-well plates were inoculated with CVB3-CKO (equivalent to 4,123
positive RNA strands, based on RT-qPCR quantitation of cDNA from virus preparations)
with or without anti-CVB3 neutralizing antibody (Fig. 4A-F, H) as described earlier (10).
After 5 days of incubation, cytopathic effects were present only in cultures inoculated
with wt CVB3 in the absence of neutralizing antibody (Fig. 4, compare panels A-E to
panel F), demonstrating that the amount of antibody used was sufficient to suppress a
productive cytopathic infection.
Successful neutralizing antibody suppression of infection should be verifiable by
an inability to detect viral RNA. To test whether viral RNA was present in the cultures
with or without neutralizing antibody, nested RT-PCR for the detection of positive strand
viral RNA was performed on total RNA prepared from cell cultures in two separate
experiments (Fig. 4G). Viral RNA was detected in wells inoculated with CVB3-CKO and
wt CVB3 in the absence of neutralizing antibody (compare Fig. 4H, lanes 4 and 5
[arrows], and Fig 4J lane 3 [CVB3-CKO] with Fig. 4H lanes 8 and 9 [wt CVB3]) but
not in wells containing antibody (compare Fig. 4H, lanes 2 and 3, and Fig. 4J lane 2
[CVB3-CKO] with Fig. 4H lanes 6 and 7 [wt CVB3]). The water (no cDNA), no
template RT-PCR, and tissue culture controls were negative (Fig. 4I, lanes 2-4 no
cDNA PCR controls, lanes 5-7 no template RT-PCR controls, lanes 8-10 tissue
culture controls). These results demonstrated that electroporation with CVB3-CKO T7
transcribed RNA produced infectious CVB3 virus particles that can be isolated and
transferred to fresh cell cultures.

CVB3 and CVB3-CKO RNA inoculated into mice generates virus. Our observations
that CVB3-CKO produced infectious virus and can be passaged in cell culture, led us to
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ask if this were reproducible in vivo. A/J mice were chosen for this experiment as longterm CVB3 persistence has been demonstrated in this strain of mouse and this strain
has been used regularly in our studies of CVB3-TD replication (10, 11, 80). Mice were
inoculated i.p. with lipid conjugated CVB3-CKO or wt CVB3 T7 transcribed RNA and
killed 8 days (wt CVB3) or 20 days (CVB3-CKO) post inoculation. Spleen and heart
RNA preparations were assayed for the presence of viral RNA by RT-PCR. It was
necessary to perform serial dilutions of RNA extracted from day 20 tissues of mice
transfected with CVB3-CKO in order to detect the low level replication of this mutant
virus against the high level background of the tissue RNA. Viral RNA was detectable
only at higher dilutions (Fig. 5A, compare lanes 4 [10 fold dilution], 5 [100 fold
dilution] and 7 [10,000 fold dilution] to lane 6 [arrow; 1,000 fold dilution], though the
required dilution varied slightly among different samples. Both CVB3-CKO and wt CVB3
RNA were detectable in spleen (Fig. 5B, lanes 7 and 8 respectively) and heart (Fig.
5C, lanes 6 and 7 respectively), demonstrating the infectivity in mice of T7 transcripts
of CVB3 genomes.
To test whether CVB3-CKO RNA detected at day 20 post transfection in mice
were encapsidated and infectious as would be expected of a true viral infection, cleared
and RNase treated spleen homogenates were inoculated onto cell cultures either with or
without prior incubation with anti-CVB3 neutralizing antibody. Spleen homogenates from
mice inoculated with wt CVB3 RNA completely lysed the monolayers by two days postexposure but for all other spleen homogenates, no CPE was evident by 5 days postexposure (Fig 5D-J): no CPE was observed in cells exposed to homogenates of wt
CVB3 transcript spleen tissue containing neutralizing antibody nor in control wells, nor in
wells inoculated with CVB3-CKO spleen homogenates (Fig. 5, compare panels D-J
with panel K). Lysis by wt CVB3 RNA demonstrated that inoculation of conjugated
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FIG. 5. T7 RNA transcripts from CVB3 and CVB3-CKO clones can be transfected
into mice and virus replicates post transfection. Nested RT-PCR could detect viral
RNA using total RNA of hearts and spleens of mice transfected with wt CVB3 or CVB3CKO T7 RNA transcripts: (A) A representative gel demonstrating the necessary 10 fold
serial dilutions of total extracted tissue RNA to detect the low level replication of CVB3CKO in mouse tissue 20 days post transfection (lane 1, HiLo marker; lane 2, no RNA
RT-PCR control; lane 3, untransfected mouse RNA; lane 4, 10 fold dilution CVB3-CKO
transfected mouse RNA; lane 5, 100 fold; lane 6, 1,000 fold; lane 7, 10,000 fold).
CVB3-CKO RNA was detectable only at a 1,000 fold dilution of RNA (A, arrow, lane 6).
(B) Detection of viral RNA in the spleens of transfected mice (lane 1, HiLo marker; lane
2, no cDNA PCR control; lane 3, no RNA RT-PCR control; lane 4, HeLa cell RNA
control; lane 5, 1,000 copies CVB3 cDNA from T7 transcripts; lane 6, untransfected
mouse RNA; lane 7, 1,000 fold dilution CVB3-CKO transfected mouse RNA at day 20;
lane 8, 100,000 fold dilution wt CVB3 transfected mouse RNA at day 8). (C) Detection
of viral RNA in the hearts of transfected mice (lane 1, HiLo marker; lane 2, no cDNA
PCR control; lane 3, no RNA RT-PCR control; lane 4, untransfected mouse RNA; lane
5, 1,000 copies CVB3 cDNA from T7 transcripts; lane 6, 100 fold dilution CVB3-CKO
transfected mouse RNA at day 20; lane 7, 10,000 fold dilution wt CVB3 transfected
mouse RNA at day 4). (D-K) RNase treated homogenates of spleens were passaged
onto HeLa cells at approximately 90% confluence and incubated overnight with (D-G)
or without (H-K) neutralizing antibodies (D and H, no homogenate; E and I, control
mouse homogenate; F and J, CVB3-CKO day 20 homogenate; G and K: CVB3 day 8
homogenate). Images at 100x original magnification. CPE was observed only in
cultures inoculated with homogenates from mice transfected with wt CVB3 RNA (K).
(L) Following five days of incubation, total RNA was tested with nested RT-PCR and
analyzed on 2% agarose gels (lane 1, HiLo marker; lanes 2-3, CVB3-CKO plus
neutralizing antibody; lanes 4-5, CVB3-CKO minus neutralizing antibody; lanes 6-7, wt
CVB3 plus neutralizing antibody; lanes 8-9, wt CVB3 minus neutralizing antibody; lane
10, no cDNA control; lane 11, no RNA RT control; lane 12, uninfected control plus
neutralizing antibody; lane 13, uninfected control minus neutralizing antibody)
demonstrating that CVB3-CKO (arrows; lanes 4-5) and wt CVB3 (arrows; lanes 8-9)
were detected in tissue homogenates following transfection of mice. Absence of
amplimers in lanes 2 and 3 (CVB3-CKO) and 6 and 7 (wt CVB3) demonstrate that virus
is neutralized by anti-CVB3 neutralizing antibody.
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CVB3 RNA generated infectious virus in tissues of transfected mice. To assay for the
presence of viral RNA in HeLa cultures that did not show CPE (CVB3-CKO and
controls), total RNA was prepared from HeLa monolayers and assayed using nested RTPCR for detection of positive strand RNA. In wells of HeLa cultures inoculated with
tissue homogenates from mice transfected with either CVB3-CKO or wt CVB3 RNAs,
viral RNA was detected at 5 days post inoculation (Fig. 5L, arrows, CVB3-CKO lanes 4
and 5, wt CVB3 lanes 8 and 9). However, when neutralizing antibody was present, no
viral RNA was detected (Fig. 5L, CVB3-CKO lanes 2 and 3, wt CVB3 lanes 6 and 7).
These results demonstrate that encapsidated, infectious virus was produced in tissues of
mice following inoculation of wt CVB3 as well as CVB3-CKO RNA. Taken together,
these results confirm that CVB3 is replication competent in the absence of a functional
(uridylylating) CRE(2C).

Discussion

Our hypothesis - that CVB3-TD viruses should be able to replicate without an
uridylylating CRE(2C) - is firmly supported by the results presented here. Previously, a
range of 5' terminal genomic deletions ranging from 7-49 nucleotides were characterized
in CVB-TD populations which arose from both experimental and naturally occurring
infections (9, 10, 13). In these CVB3-TD genomes, while VPg remained attached to the
5’ terminus, only 1 (of 5) of the naturally-occurring deletions that were characterized,
terminated in the UU that would normally be donated by uridylylated VPg at the start of
replication (10). If CRE(2C)-uridylylated VPg were used in CVB3-TD virus positive
strand initiation, CVB3-TD viral genomes would have been expected to have a higher
proportion of 5’ terminal uridine residues than has been observed. The results
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presented here demonstrate that mutational disruption of the CRE(2C) structure using
the 16 mutations previously shown to prevent uridylylation and inhibit replication (24),
does not prevent replication of CVB3-TD, as shown by an insignificant impact on
replication of TD viruses when assayed by RT-qPCR (Fig. 2B). We conclude that a
functional CRE(2C) (defined as able to uridylylate VPg) is not necessary for CVB3-TD
replication.
However, a most unexpected result from this work came from an intended
control: the mutationally disrupted CRE(2C) structure in the wt CVB3 genome (CVB3CKO). We fully expected this construct to show, as others had previously (24, 27, 45,
75), that an uridylylating CRE(2C) is necessary for CVB replication and that mutational
disruption of the element would result in lost replication capacity. We were surprised,
therefore, to observe that the strain termed CVB3-CKO, containing 16 silent mutations
which ablate VPg uridylylation, was replication competent and able to be passaged in
cell culture after isolation of viral particles. Our ability to isolate virus, and subsequently
viral RNA, after RNase treatment and sucrose purification demonstrated that de novo
replication was occurring following transfection of CVB3-CKO RNA, as only newly
synthesized RNA is encapsidated (55). The additional finding that CVB3-CKO was
viable in mice following inoculation of viral RNA transcribed from the infectious CVB3CKO cDNA clone, confirmed and significantly extended findings derived from the cell
culture system. These results are in sharp contrast to those of van Ooij and colleagues
(24) who reported that these same 16 mutations when induced into CVB3 [albeit a
different strain of CVB3 (81) than used in these studies CVB3/28 (30)], were lethal as
demonstrated by a lack of observable CPE in BGM cell cultures, a lack of detectable
luciferase activity 10 hours post transfection in BGM cells (when the P1 region had been
replaced with a luciferase gene), and an undetectable level of single-stranded RNA
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production in cell-free assays (24). The disparity between our results and those of van
Ooij and colleagues (24) regarding the impact of the mutated CRE(2C) on CVB3
viability, can best be explained by the type and sensitivity of the assays used to assess
the viability of these viruses and the ability of these viruses to replicate at detectable
levels over an extended time (days) in culture. Differing effects may also be seen in
various cell lines although this was not tested in the work reported here.
Yet another unexpected finding occurred while performing this work: the
replication of the wt CVB3 genome with the mutationally disrupted CRE(2C) structure is
associated with the development of a CVB3-CKO virus population possessing 5' terminal
deletions. As in earlier studies (10), the CVB3-CKO-TD population is detectable in the
complete absence of the wt (or parental) initiating genome population, and thus does not
require the presence of the wt genome to replicate successfully. This novel finding
demonstrates that while an important part of the normal and efficient initiation of wt virus
positive strand synthesis requires the CRE(2C) structure and function to be intact, virus
replication can still occur in the absence of both. This may occur by a lack of specific
initiation of replication caused by two potential mechanisms. In the first, a lack of
specific VPg uridylylation on a functional CRE(2C) could lead to VPg nucleotidylation at
the site of RNA replication initiation. The absence of the 2 uridine residues linked to VPg
during CRE(2C) mediated uridylylation would prevent annealing to the 2 adenine
residues at the 3’ terminus of the viral negative RNA strand. In the second scenario,
perhaps the 3D interaction with VPg in the absence of the native CRE(2C) stem-loop
structure prevents formation of the native initiation complex that would confer specificity
to the 3’ end of the negative strand (82, 83).
Our findings that CVB-TD genomes evolve successfully and replace the initiating
wt population completely only in primary cell cultures and terminally differentiated tissues
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(9, 10, 13) was hypothesized to occur due to a relative lack of the host protein
heterogeneous nuclear ribonucleoprotein C1 (hnRNPC1) which is found at high levels in
the cytoplasm only in transformed and dividing cells (84-86) and which is necessary for
efficient positive strand RNA replication (87, 88). Alteration in the 3’ end of the negative
strand (which occurs in CVB-TD populations) should decrease positive strand synthesis
because the viral proteins 2C and 2BC (89, 90), along with hnRNPC1, bind negative
strand RNA in this region and, upon interaction with viral protein 3CDpro, are thought to
mediate initiation of positive strand replication (88). It has been hypothesized that in
quiescent or terminally differentiated cells and tissues, wherein hnRNPC1 becomes
sequestered in the nucleus, an absence of cytoplasmic hnRNPC1 hinders specific
(proper) initiation of enteroviral positive strand synthesis. Improper initiation at sites
downstream of the 3' terminus, due to a lack of hnRNPC1 in the replication complex,
then leads to generation of 5’ terminally deleted (TD) genomes (10). However, in HeLa
cells, a transformed and rapidly dividing cell line, hnRNPC1 is present in the cytoplasm
and therefore, TDs have not been observed: our previous work showed that CVB3-TD
virus populations were not detectable even after repeated passages of CVB3 in HeLa
cells (13). But as replication of CVB3-CKO generates 5’ terminal deletions (described
above) a role for the CRE(2C) in the correct initiation of positive strand RNA can be
strongly inferred, even in cells with high levels of cytoplasmic hnRNPC1. From the
observations that deletions of the 5’ end of the genome or mutations in the CRE(2C)
result in a similar level of viral RNA replication, and the presence of both lesions in a
single genome do not have an additive effect upon the extent of replication, it is clear
that both these sites are required for the process of efficient (and correct) positive strand
initiation. These findings also indicate that the "fall back method” of initiation (a nonspecific initiation), seen in non-dividing cells in culture and in tissues when cytoplasmic
hnRNPC1 is lacking (6, 10, 13) and in this study when CRE(2C) is disrupted, is one in
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which the 5’ terminal deletions are generated. This implies that even in transformed
cells with an abundance of cytoplasmic hnRNPC1, that a functional CRE(2C) is required
or the virus replicates with a nonspecific and much less efficient initiation of positive
strand RNA.
At this juncture, we have shown that CVB3, a typical enterovirus, can replicate
with low efficiency (compared to wt CVB3) without two of the four known cis-acting
elements required for replication (17, 58): namely, domain I in the 5' NTR and the
CRE(2C). Thus, replication in the absence of both domain I and the CRE(2C) has not
been seriously considered to date due to the experimentally verified importance of these
structures for HEV replication (19, 24, 45, 62). That said, it has been demonstrated that
a loss of another HEV cis-acting replication element, the 3’ NTR, does not prevent
replication either (91, 92). At the 3’ end of the genomic RNA in the poly A tract, a
ribonucleoprotein complex forms with the binding of viral protein 3CDpro and the host
protein poly(A) binding protein (PABP) (68). Despite the apparent replication
requirement for protein binding in the 3’ NTR for viral replication, Todd and colleagues
(1997) demonstrated that both poliovirus and human rhinovirus 14 were replication
competent, albeit with delayed growth phenotypes, when the 3’ NTRs were entirely
deleted (92). A more recent study elaborated on this work, demonstrating an
approximate five-log decrease in plaque forming units per microgram of RNA following
transfection of poliovirus T7 transcripts with deleted 3’ NTRs, but only an approximate
one-log decrease in infectivity of recovered virions (91). These findings demonstrated
that at least one of the required cis-acting replication elements could be deleted from a
HEV genome without lethality and that it has a relatively small impact on infectivity in
recovered virus. In addition, Goodfellow and colleagues (2000) demonstrated that after
introducing two and five mutations into the poliovirus CRE(2C), a return to a wt lytic
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phenotype occurred after serial blind passage despite the fact that no CPE was
observed upon initial transfection (19). The ability of these viruses to revert
demonstrates that replication was occurring in the absence of a wt CRE(2C) structure
and lends support to our findings that mutational disruption of the CRE(2C) is not lethal.
The poor extents of replication of the CVB3-TD strains as well as the CVB3-CKO
and CVB3-TD50-CKO strains led us to investigate the use of transfecting viral genomic
RNA into mice as an alternative approach to generating virus. We used only one
transfection reagent, LIPID-based In Vivo Transfection Reagent (Altogen Biosystems),
but from the results obtained here (Fig. 5), it would appear that this approach has
potential for studying diverse in vivo aspects of the biology of these inefficiently
replicating virus strains, as well as the host response to infection by such viruses,
without having to laboriously produce virus stocks from cell culture. To the best of our
knowledge, this represents the first report of generating infectious virus by i.p. lipid
based transfection of animals with a picornaviral RNA, though others have previously
described methods to inoculate mice with viral DNA or RNA. Direct injection of mice
with polyoma virus DNA suspended in saline or TNE buffer (93, 94) and direct injection
of HBV DNA in chimpanzees (95) has been useful for studying these DNA viruses
without the necessity of preparing infectious virions. Further, direct injection of the
tibialis anterior muscle of mice with CVB3 RNA suspended in saline demonstrated that
wt virus could be recovered several days post inoculation (96). However, the method
described in this report may be more efficient than the methods previously reported, as it
uses a reagent designed for in vivo RNA transfection.
Specific initiation at the 3’ end of the negative strand template is critical to
positive strand RNA viruses in order to avoid loss of genome during replication. We
demonstrated an increase in the extent of loss of 5’ terminal sequence by passage in
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cell culture and in animals of CVB3 with a small terminal deletion (13) which led to the
conclusion that the persisting CVB3-TD viruses are an evolutionary dead end despite
the ability to prolong enterovirus infection in tissues. Based on our findings, it is
tempting to speculate that the mutant virus genomes described in this work represent
what may have been one of any number of primitive ancestors at one time in the
evolutionary development of the HEV. The HEV ancestral genome would have likely
been a basic replicon which evolved CRE structures to generate more efficient
replication and dissemination in the face of increasingly effective host antiviral defenses.
It remains to be seen what else might be deleted from an HEV genome in terms of
critical elements that affect replication and still have replication competency.
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Chapter 3

A uridylylation incompetent CRE(2C) of coxsackievirus B3 is viable and reverts to
wildtype following passage in cell culture or mice.

Introduction

RNA virus populations exist as a quasispecies consisting of a spectrum (or
swarm) of related genomes that are heterogeneous in nature (33). The variability of
genetic sequence within the variant (mutant) spectrum allows for competition and
selection of the fittest viruses in a given environment (33). These heterogeneous viral
populations are generated within individual cells, groups of cells, and within infected
organisms after experimental and natural infection (97-99) due to recombination and the
error prone nature of the RNA-dependent RNA polymerase (RdRp) (34, 37, 100, 101).
The error rate of the RdRp of RNA viruses is between 1,000,000-times higher than that
of the DNA-dependent-DNA-polymerase replicating chromosomes in cells (55, 102).
The RNA viruses studied in our laboratory are the coxsackie B viruses (CVB;
serotypes 1-6) which are small, non-enveloped, single-stranded RNA viruses classified
in the human enterovirus genus of the Picornaviridae (55). The CVB have been
etiologically associated with a variety of human diseases including type I diabetes,
pancreatitis and myocarditis (4-8, 30). Previous work in this laboratory identified a
persistence mechanism of the CVB via 5’ terminal genomic deletions (CVB-TD) (10).
The characterized populations of CVB-TD exhibited deletions ranging from 7-49
nucleotides, partially eroding domain I (10), the important cis-acting replication element
(CRE) for efficient viral genome replication (25, 60-64). CVB-TD populations arise
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following naturally-occurring human and experimental CVB infections of cell cultures or
mice, thereby demonstrating that formation of TDs is a natural mechanism in the CVB
(9, 10, 13). Poliovirus has also been found to persist for up to a year in the motor
neurons of immunocompetent mice in the absence of cytopathic virus, suggesting (but
not yet experimentally verified) that this HEV may also form TD populations (103).
Located within the 2C protein coding region of the HEV genome is a stem-loop
structure termed CRE(2C), which has been shown to be the template for uridylylation of
the viral protein primer VPg (14, 24, 73). Recently, we demonstrated that wildtype (wt)
CVB3 was also replication competent when the CRE(2C) (Fig. 6) was mutationally
disrupted [termed CVB3-CKO] (see chapter 2 of this dissertation). Prior to our studies,
mutational disruption of the CRE(2C) in both poliovirus and CVB3 genomes had been
considered to be lethal when studied using cell free assays to measure genome
replication, VPg uridylyation through autoradiographic assays (24, 27, 45, 75), and by
luciferase and cytopathic effect assays in BGM cells after short incubation times (24).
We demonstrated (chapter 2), however, that not only could infectious virus be
isolated from cells electroporated with T7 RNA polymerase transcribed CVB3-CKO RNA
but that recovered virions were inhibited by neutralizing antibody in cell culture, thus
demonstrating the virions' infectivity (chapter 2). Another surprising finding from our cell
culture work demonstrated that 5’ terminal deletions (TDs) were occurring in CVB3-CKO
after eight days of replication in HeLa cells (chapter 2); this was unexpected because
generation of 5’ terminal deletions do not occur during wt CVB infection of transformed
cell lines such as HeLa cells (10). Further, we explored whether or not CVB3-CKO was
infectious in mice using in vivo lipid transfection of infectious CVB3 T7 transcribed RNA
(chapter 2). We demonstrated that CVB3-CKO RNA was detectable 20 days post
transfection in both the spleens and hearts of mice and that infectious virions were
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FIG. 6. The CRE(2C) of CVB3 with mutations indicated. The sequence of the
CRE(2C) of CVB3 from nucleotides 4369-4421. Nucleotides changed to generate
CVB3-CKO are indicated by italicized letters above the wt sequence. The numbering of
the loop is indicated beginning with number 1 (G) and proceeding around the loop to
number 14. Red nucleotides in the loop indicate the template nucleotides used for VPg
uridylylation.
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present using neutralizing antibody assays (chapter 2). The results of these mouse
studies elaborated on and extended the cell culture findings, further illustrating that a
functional CRE(2C) was not required by CVB3 for replication to occur (chapter 2).
The finding that CVB3-CKO was replication competent, and that 5’ TDs were
occurring at day eight post electroporation of HeLa cells (chapter 2), led us to question
what was occurring to the mutated sequence in the CRE(2C) region of the genome:
specifically, do reversions occur or do the mutations remain intact? In preliminary
experiments to explore this question, we enzymatically amplified then sequenced across
the CRE(2C) region of CVB3-CKO at day eight post electroporation of HeLa cells and
observed that the CRE(2C) had completely reverted to a wt sequence. The finding that
16 mutations had completely reverted was so unexpected that we suspected an artifact
and so repeated this same experiment numerous times, each time observing the same
result. Clearly, the mutated CRE(2C) was reverting to the wt sequence.
Based on these findings, we hypothesized that during persistent replication in cell
culture, high selective pressure drives the complete reversion of the mutated CRE(2C) to
a wt sequence, thereby restoring the wt stem-loop structure, and that this occurs
following evolution of 5’ TDs in the majority population. Indeed, the data described
below show that until eight days post electroporation, the 16 mutations introduced into
the CRE(2C) largely remain intact in the majority of the genomes [(24); see chapter 2 of
this dissertation]. Then, by 8 days post-electroporation, a majority population arises that
has completely reverted to wt sequence. Further, we show by sequencing various ratios
of complementary DNA (cDNA) clones that at a 4:1 ratio of wt:CVB3-CKO, only wt
sequence can be detected. This control demonstrated that a relatively low ratio of wt
revertants amongst a larger population of the mutated CKO would not be detectable by
standard sequencing and thus a significant amount of reversion could be - and indeed is
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- generated prior to the time that the reverted CRE(2C) was detectable. Finally, we
show that TDs evolve in the majority population prior to the time of complete reversion of
the CKO to wt sequence, thereby preventing the detectable presence of CPE that would
be expected in cell culture were the CRE(2C) to revert with an intact 5’ genomic
terminus.

Materials and Methods

Cells and virus. Coxsackievirus B3/28 (30) is the wt virus used in this work. Mutations
were engineered in the CRE(2C) region of the wt or CVB3-TD50 cDNA clones as
described previously (chapter 2) to create the CRE(2C)-knock-out (CKO) strains, CVB3CKO and CVB3-TD50-CKO respectively. HeLa cell monolayer cultures were maintained
as described previously (chapter 2). Viral stocks were prepared by electroporation of
HeLa cells with T7 transcribed RNA from infectious cDNA clones of each viral genome
and, following incubation for 1 to 8 days (CVB3-CKO) or 8 days (CVB3-TD50, CVB3TD50-CKO, and wt CVB3), virus was biophysically purified as previously described
(chapter 2).

Transfection of mice with viral T7 transcribed RNA. The University of Nebraska
Medical Center Institutional Animal Care and Use Committee approved the protocol and
use of mice for transfection studies. Male A/J mice (6-7 weeks old; Jackson Laboratory,
Bar Harbor, ME) were inoculated intraperitoneally (i.p.) with CVB3-CKO T7 transcripts
as previously described (chapter 2). Spleens and hearts were excised at 20 days posttransfection and prepared as previously described (chapter 2). Total RNA was extracted
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from tissues by homogenization in 500 μL TRizol (Invitrogen; Carlsbad, CA) and
assayed as described below in “enzymatic amplification of the CRE(2C) sequence”.

Enzymatic amplification of the CRE(2C) sequence from virus preparations and
mouse tissues. To assay for reversions in the CRE(2C) region of CVB3-CKO and
CVB3-TD50-CKO, cDNA was transcribed from virus preparations (CVB3-CKO [1, 3, 5,
6, 7, and 8 days post-electroporation]; CVB3-TD50-CKO [8 days post-electroporation];
CVB3-TD50 control [8 days post-electroporation]; wt CVB3 [pass 3, 8 days postelectroporation]) and from day 20 post-transfection mouse tissues (CVB3-CKO only)
with primer 4523Rev (Table 1) at a final concentration of 2 μM using Improm II reverse
transcriptase (Promega, Madison, WI) as previously described (chapter 2). The
CRE(2C) region was amplified using nested primers in 20 μL reaction volumes
containing GoTaq Green Master Mix (Promega) as described previously (chapter 2).
Briefly, cDNA was amplified in initial enzymatic reactions with primers 4523Rev and 2B1
at a final concentration of 0.5 μM each (Table 1; 2), followed by ethanol precipitation and
amplification with primers 2C2 and 2C7 (Table 1; 2). For virus preparations at days 6, 7
and 8 post-electroporation, two concurrent amplifications with primers 2C2 and 2C7
were carried out in addition to, and in lieu of, the nested PCR described above; this
yielded better sensitivity at these time-points which had scant RNA for cDNA
preparation. PCR reactions were electrophoresed on 2% agarose gels and bands at the
appropriate size (Table 2) were excised and purified using the Zymoclean Gel DNA
Recovery Kit (Zymo Research; Irvine, CA) as previously described (chapter 2).
Reactions were sequenced at the UNMC core facility.
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Nested RT-PCR for detection of viral RNA in virus preparations. To assay for viral
RNA in ultracentrifuged sucrose purified virus preparations, nested RT-PCR was
performed as previously described (chapter 2). Briefly, cDNA was primed with E3
(Table 1) as described in “enzymatic amplification of the CRE(2C) region” followed by
enzymatic amplification using primers S4 and E3Sub (Table 1; 2) in GoTaq Green
Master Mix (Promega). Reactions were ethanol precipitated and a second PCR was
carried out using primers S5 and SReturn (Table 1; 2). Final PCR products were
analyzed on 2% agarose gels.

Quantitation of CVB3-CKO replication at various time points and titering of viral
RNA in purified virus stocks using RT-qPCR. Mutant viruses (CVB3-CKO, CVB3TD50, and CVB3-TD50-CKO) do not cause CPE in tissue culture monolayers, therefore
viral RNA copy number was quantitated using RT-qPCR as described previously
[chapter 2; (10)] as a measurement of virion titer. cDNA was transcribed with primer E3
(Table 1) as described in “enzymatic amplification of the CRE(2C) region” above. As
previously described (chapter 2), RT-qPCR was performed using an Opticon 2 DNA
Engine (MJ Research) using primers E2 and E3Sub (Table 1) in Maxima SYBR
Green/Fluorescein qPCR master mix (Thermo Scientific). Reaction parameters were as
previously described (chapter 2) and as indicated (Table 1; 2)

RT-PCR to detect 5’ terminal deletions in purified virus stocks. To determine the
point at which 5’ terminal deletions occur over a time-course of CVB3-CKO replication,
cDNA was primed with E3 (Table 1) as described in “enzymatic amplification of the
CRE(2C) region” above. To ensure results were comparable, reverse transcriptase
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reactions were assembled with an equal RNA copy number calculated as previously
described (chapter 2). Tagged primers [(78); chapter 2] were used to detect 5’ terminal
deletions. Briefly, initial enzymatic amplification was carried out using Pin5End1 and E3
(Table 1; 2) and 500 copies of E3 cDNA or Pin5End5 and E3 (Table 1; 2) with 1,500
copies (near the experimentally determined limit of detection for the respective primer
pairs), in GoTaq Green Master Mix (Promega), followed by ethanol precipitation and a
second round of enzymatic amplification using primers Pin and SReturn (Table 1; 2).
PCR products were analyzed on 2% agarose gels.

Results

The 16 CKO mutations have completely reverted to the wt sequence by 8 days
post-electroporation of HeLa cells. Our previous findings (chapter 2) demonstrated
that CVB3-CKO and CVB3-TD50-CKO were both viable in cell culture following
electroporation of T7 transcribed RNA, and that CVB3-CKO was viable in mice following
transfection of T7 RNA polymerase transcribed RNA. Further, it was demonstrated that
CVB3-CKO from purified virus preparations, or from mouse tissue homogenates, could
be passaged in cell culture and infection was inhibited by anti-CVB3 neutralizing
antibodies (chapter 2). The fact that this virus was replicating despite the findings of
others (24, 45), led us to question whether or not the 16 mutations introduced in the
CRE(2C) region of CVB3-CKO remained present, or if reversions were occurring in this
region after several rounds of replication in either cell culture or within the tissues of
transfected mice. To answer this question, cDNA was prepared using viral RNA
extracted from either purified virus preparations (CVB3-CKO or CVB3-TD50-CKO [wt
CVB3 and CVB3-TD50 were tested as controls]) or from mouse tissues at 20 days post
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transfection (CVB3-CKO) and the CRE(2C) region was enzymatically amplified and
sequenced; wt and CVB3-CKO clones were used as controls. Alignments of amplified
CRE(2C) sequences were subsequently conducted (Fig. 7).
The sequence of the total amplimer population indicated that at days 1 (Fig. 7A
row 5), 3 (Fig. 7A row 6), and 5 (Fig. 7A row 7) post electroporation of HeLa cells with
CVB3-CKO T7 transcribed RNA, the 16 mutations made in the CRE(2C) region
remained intact in the purified CKO virus when compared to the wt cDNA clone and T7
transcribed RNA (Fig. 7A row 1;2 respectively) or the CVB3-CKO cDNA clone and T7
transcribed RNA (Fig. 7A row 3;4 respectively). These data demonstrated that
reversions had not occurred in the majority CVB3-CKO population up to 5 days postelectroporation of HeLa cells; that is to say, the majority population still appeared to be
mutant by sequence analysis. Surprisingly, by day 8 post electroporation, the 16
mutations had appeared to completely revert to that of the wt sequence (compare Fig.
7A row 8;9 to Fig. 7A row 1;2 [wt] and Fig. 7A row 3;4 [CVB3-CKO]). This was
repeated using 5 different purified CVB3-CKO virus preparations from day 8 postelectroporation with the same results (two representative sample sequences are shown
in Fig. 7A). To determine whether reversions were present in the tissues of mice at day
20 post transfection, the CRE(2C) region was amplified using the same method
described for the purified virus preparations. Analysis of sequences from day 20 posttransfection spleen and heart demonstrated that complete reversion to the wt sequence
had occurred in the CRE(2C) region of CVB3-CKO (compare Fig. 7A row 10 and Fig.
7A row 11 respectively, to Fig. 7A row 1;2 and Fig. 7A row 3;4). These data were
repeated by assaying a different mouse heart and spleen (data not shown). A
representative selection of sequencing chromatograms from days 1, 5, and 8 post-
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FIG. 7. The CRE(2C) of CVB3-CKO completely reverts to a wt sequence by 8 days post-electroporation
in HeLa cells and by 20 days post-transfection in mouse tissues. (A) Sequence alignments of cDNA clones
(1 [wt CVB3] and 3 [CVB3-CKO]), T7 transcribed RNA from cDNA clones (2 [wt CVB3] and 4 [CVB3-CKO]),
RNA from purified virus preparations at various time-points post-electroporation of HeLa cells (5 [CVB3-CKO 1
day post-electroporation], 6 [CVB3-CKO 3 days post-electroporation], 7 [CVB3-CKO 5 days post
electroporation], 8 [CVB3-CKO 8 days post-electroporation; virus preparation 1], 9 [CVB3-CKO 8 days postelectroporation; virus preparation 2], 12 [CVB3-TD50-CKO 8 days post-electroporation], and 13 [CVB3-TD50 8
days post electroporation]), and mouse tissues 20 days post-transfection (10 [CVB3-CKO; mouse heart] and 11
[CVB3-CKO; mouse spleen]). Underlined nucleotides indicate wt sequence and bold, dot underlined sequence
indicates CKO mutations. By 8 days post-electroporation of HeLa cells with CVB3-CKO T7 transcribed RNA,
the CRE(2C) sequence had completely reverted to wt (compare A5-7 [days 1, 3, and 5 post-electroporation] to
A8 and A9 [two different 8 day virus preparations] or controls A1;2 [wt CVB3 clone and T7 transcript
respectively] and A3;4 [CVB3-CKO clone and T7 transcript respectively]. This was also observed in mouse
tissues at 20 days post-transfection with CVB3-CKO (A10 [heart] and A11 [spleen]) and at 8 days postelectroporation of HeLa cells with CVB3-TD50-CKO (A12). (B-D) Representative sequence chromatograms
from CVB3-CKO at (B) 1 day post-electroporation of HeLa cells, (C) 5 days post-electroporation, and (D) 8 days
post electroporation demonstrating that sequence reads were clean.
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electroporation of cell culture demonstrate that sequencing reads were clean (Fig. 7BC). These results supported and extended the findings observed in cell culture,
demonstrating that complete reversion to wt sequence was occurring in the CRE(2C) of
CVB3-CKO. Because we observed a complete reversion of the CRE(2C) in CVB3-CKO
after 8 days of replication in HeLa cells, and after 20 days in the tissues of transfected
mice, we wished to determine if reversions were occurring in the CVB3-TD50 population
when the CRE(2C) was mutated in the same way (CVB3-TD50-CKO). Using CVB3TD50 as a control, analysis was conducted on CVB3-TD50-CKO and CVB3-TD50 as
described for CVB3-CKO. Based on sequence analysis at 8 days post-electroporation
of HeLa cells, a complete reversion of the CRE(2C) to wt sequence occurs in the CVB3TD50-CKO population as well (compare Fig. 7A row 12 to Fig. 7A row 13 and Fig. 7A
row 12 to Fig. 7A row 1;2 [wt] and Fig. 7A row 3;4 [CVB3-CKO]). These findings
demonstrated that, regardless of whether the 5’ terminus was intact or not when
replication began, sequences within the CRE(2C) were indistinguishable from that of the
wt CVB3 by 8 days post-electroporation in HeLa cells (CVB3-CKO and CVB3-TD50CKO) or in the spleens and hearts of mice at day 20 post-transfection (CVB3-CKO).

Standard Sanger sequence analysis is an inefficient assay for the presence of
accumulating mutations in a mutant swarm. We observed complete reversion to wt
sequence in the CRE(2C) after 8 days of replication in HeLa cells, although prior to this
time, the sequence of amplified cDNA showed only the induced mutations. We
hypothesized that prior to the appearance of the complete reversion of 16 nt at 8 days, a
growing population of revertants was present within the mutant cloud but that the
dominant population masked detection of these changes. To test this hypothesis, a
simple experiment was performed in which 2-fold increases of wt CVB3 cDNA clone
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(from 1.62x109 copies to 1.30x1010 copies) were mixed with a constant copy number of
CVB3-CKO clone (1.62x109 copies) providing ratios of 1:1 to 8:1. Reaction mixtures
were sequenced using primer 2C7 (Table 1), after which sequencing chromatograms
were compared (Fig. 8). When comparing the CVB3-CKO clone (Fig. 8A) to the wt
CVB3 clone (Fig. 8F), the sequences were as expected and confirmed that the expected
CKO mutations were present in the CVB3-CKO clone used in these studies. At a DNA
copy ratio of 1:1 (wt:CVB3-CKO [Fig. 8B]) it is also apparent that both sequences are
detected equally as demonstrated by the presence of two peaks corresponding to two
different nucleotides in the sequencing chromatogram. This indicates that at a copy ratio
of 1:1 in an amplimer population, both sequences would be readily detectable. At a copy
ratio of 2 wt to 1 CVB3-CKO (Fig. 8C), it is evident that the mutant sequence is already
partially obscured by the two-fold majority wt sequence; this is indicated by the finding
that 10 of the 16 mutations appear as wt in the chromatogram, although two peaks are
still evident at each mutation (Fig. 8C, arrows). At a ratio of 4:1 (Fig. 8D), the 16 CKO
mutations are nearly too completely masked by the wt sequence with only minor
secondary peaks detected in the sequencing chromatogram in these regions. No
difference in sequence chromatograms was observed when comparing a ratio of 4:1 and
8:1(compare Fig. 8D [4:1] to Fig. 8E [8:1]). This indicates that when exploring a
potentially mixed population, such as would be expected after days of replication in
cells), only the majority population would be detectable using standard sequencing and
that a majority population would need to be present at least at a 25% level in order to be
detected.
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FIG. 8. Standard Sanger Sequence analysis is inefficient at detecting mutations in a mixed
population. (A-C) Sequencing was conducted on mixed population of cDNA clones of wt CVB3
and CVB3-CKO, with the concentration of CVB3-CKO being held constant and the concentration of
wt CVB3 increasing by 2-fold to a final ratio of 8:1; underlined nucleotides indicate the 16
nucleotides mutated to generate CVB3-CKO from wt. (A) The DNA sequence of the CVB3-CKO
CRE(2C) region using primer 2C7 (Table 1). (B) A 1:1 ratio of wt:CVB3-CKO demonstrates that
both sequences are detected at near equal efficiency as indicated by double peaks (the box
highlights a representative region with double peaks) and nucleotide ambiguity codes at positions
corresponding to variable regions (red arrows). (C) At a ratio of 2:1, the wt sequence begins to
obscure and mask the CKO sequence with only 6 of the 16 CKO mutations detectable (red arrows).
(D-F) At a ratio of 4:1 wt:CVB3-CKO (D) and 8:1 wt:CVB3-CKO (E), the CKO mutations are no
longer detectable as compared to the wt cDNA clone sequence chromatogram (F). Therefore,
when 1 in 4 molecules contains the mutant sequence (CVB3-CKO) it is no longer detectable by
standard sequencing.
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Contamination with wt virus or T7 transcribed RNA is unlikely. To test the
hypothesis that contamination may have been responsible for our observations, we
reasoned that wt CVB genomes, if co-transfected with the replication impaired CVB3CKO genomes, would result in rapid dominance of wt replication which would be
apparent by the induction of CPE. This was tested by transfecting wt (cytopathic) CVB3
T7 transcribed RNA into HeLa cell monolayers in increasing amounts (10, 100, and
1,000 copies), while holding the copy number of (non-cytopathic) CVB3-CKO T7
transcribed RNA constant at 1.97x1011 copies. Previous work by Crowder and
Kirkegaard (74) demonstrated that when one or two mutations were made in the loop of
the CRE(2C) of poliovirus, a dominant negative effect occurred during co-infection with
wt poliovirus. However, when multiple mutations throughout the stem and loop of the
CRE(2C) were introduced, no inhibition of wt replication occurred (74). Based on these
findings we did not expect a dominant negative effect on the replication of wt from a
complete (16nt) disruption of the CRE(2C) as in CVB3-CKO. HeLa cell monolayers
were observed for the presence of CPE every 24 hours for a period of 5 days. Complete
CPE was observed in all monolayers transfected with 100 and 1,000 copies of wt CVB3
RNA in the presence of CVB3-CKO RNA, and in all wt RNA only control wells
transfected regardless of the RNA copy number, after 24 hours of replication (Table 3).
In contrast, CPE was not observed in wells transfected with CVB3-CKO RNA alone or in
wells transfected with CVB3-CKO RNA and 10 copies of wt T7 transcribed RNA at 5
days post-transfection (Table 3). However, CPE was evident after two blind passages
of frozen-thawed lysates to fresh cell cultures from the 10 wt CVB3 RNA copies plus
CVB3-CKO RNA. In no case (1-3 blind passages) did lysates from CVB3-CKO RNA
only cells cause CPE on fresh cell cultures. These results demonstrated that CVB3CKO virus preparations which were assayed for reversions were not contaminated with
wt CVB3, and supported our earlier observations that CVB3-CKO purified virus prepar-
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Table 3. Experimental contamination of CVB3-CKO T7 transcribed RNA transfections
with wt CVB3 T7 transcribed RNA demonstrate wt CVB3 rapidly becomes dominant.
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ations do not induce CPE upon passage (chapter 2). Further, previous work by de la
Torre et al. suggested that, when studying rapid reversion in poliovirus, wt virus would
have to contaminate viral preparations with equal efficiency and at very high levels for
contamination to be a considerable explanation (43). Contamination of primers was also
ruled out by conducting 10 replicate enzymatic amplifications containing only water,
enzyme mix, and primers 2C2 and 2C7 (Table 1;2), all of which were negative when
assayed on 2% agarose gels (data not shown).

Compensatory mutations are extremely unlikely in the stem of CRE(2C) in CKO
viruses. The mutations introduced into the CRE(2C) were synonymous (third-base
mutations within codons in the protein 2C coding region). However, those nucleotides
which paired with the mutated bases held either first or second positions in codons
within the 2C region and, therefore, we did not expect compensatory mutations to occur.
To explore whether or not compensatory mutations could occur within the stem of the
CRE(2C) in CVB3-CKO, our analysis of possible compensatory mutations in this region
of all HEV-B genomes was conducted using GenBank (Fig. 9). The presence of
compensatory mutations is unlikely in the stem of the CRE(2C) because all
compensatory mutations would alter amino acid coding. This is supported by the finding
that only one compensatory mutation has been reported in the HEV-B 2C protein,
causing a E121K change (Fig. 9A,B; boxes and arrows). Compensatory mutations
were not addressed in the loop region of the CRE(2C) as there are no defined binding
partners for nucleotides in the loop (Fig. 9B); therefore, we were unable to predict
possible compensatory mutations in this region of the CRE(2C). However, upon
analysis of 35 random EV-B sequences in GenBank, no deviation from the sequence of
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FIG. 9. Compensatory mutations are unlikely in the stem of the CRE(2C). (A) Sequence
analysis using NCBI was used to explore the possibility of compensatory mutations in the
CRE(2C) of CVB3. Sequences are of cDNA copies of viral RNA deposited in GenBank. All
compensatory mutations would affect the amino acid sequence of the 2C protein. Only 1
compensatory mutation was reported to exist in 429 HEV-B sequences examined (box and
arrows). (B) Location of the compensatory mutation in the CRE(2C) secondary structure (box
and arrow).
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the CRE(2C) loop (Fig 9B) of wt CVB3/28 was found (data not shown).

5’ terminal deletions occur prior to complete CRE(2C) reversion during low-level
persistent replication of CVB3-CKO. Our previous work demonstrated that by day 8
post electroporation of HeLa cells, the CVB3-CKO had lost up to 20 nucleotides from the
5’ genomic terminus in the majority (detectable at our level of sequencing sensitivity)
population (chapter 2). This phenomenon has also been observed to occur naturally in
the CVB after experimental inoculation of mice and primary cell cultures and after natural
infection in humans, leading to a persistent, low-level infection (9, 10, 13). Replication of
CVB3-CKO is also a low-level persistent replication (Fig. 10A) which results in complete
reversion of the 16 mutations introduced in the CRE(2C) stem and loop overtime.
Because, we observed that by day 8 post-electroporation in HeLa cells, the mutations
introduced into the CRE(2C) of CVB3-CKO had completely reverted to wt in the majority
population, we asked if 5’ TDs occurred prior to reversion of the CRE(2C). We expected
that this would be the case; if reversion occurred prior to the generation of 5’ TDs, the
population of CVB3-CKO would effectively become wt [with a natural CRE(2C) and
intact 5' genomic termini] and CPE would then be detectable in cell culture. Notably,
CPE was not observed with CVB3-CKO in either of these experimental conditions
(chapter 2). Therefore, we analyzed the 5’ genomic terminus of purified virus
preparations of CVB3-CKO at days 1, 3, 5, 6, 7, and 8 post electroporation as described
above and previously (chapter 2) to test if 5' terminal genomic deletions were occurring.
These results demonstrate that at days 1 and 3 post-electroporation, viral RNA
from purified CVB3-CKO virus preparations still has an intact 5’ genomic terminus from
nucleotides 1-10 when compared to the wt CVB3 virus control or the CVB3-CKO T7
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FIG. 10. 5’ terminal deletions occur between days 3 and 5 post electroporation of
HeLa cells with CVB3-CKO T7 transcribed RNA. (A) A time-course prepared using
RT-qPCR and a minimum of 4 replicate points per time-point. The data demonstrate
the low-level persistent replication of CVB3-CKO during which 5’ terminal deletions
occur prior to reversion of the CKO mutations in the CRE(2C) to wt sequence. (B-D) To
detect 5’ terminal deletions agarose gel analysis of E3 primed cDNA amplified with
primers Pin5End1 and E3 corresponding to nucleotides 1-10 and the 5’ genomic
terminus (B-D lanes 2, 5, 8, and 11) Pin5End5 and E3 corresponding to nucleotides
15-25 (B-D lanes 3, 6, 9, and 12), then subsequently amplified with primers Pin and
SReturn was performed. To detect virus using a region of the 5’ NTR not found to
delete, gel analysis of E3 primed cDNA amplified with primers S4 and E3Sub (B-D
lanes 4, 7, 10, and 13), then subsequently amplified with primers S5 and SReturn was
performed. 500 (Pin5End1; S4) or 1,500 (Pin5End5) copies of cDNA prepared from
either viral RNA or T7 transcribed RNA (control) were used in each PCR reaction.
Right facing arrows indicate the loss of sequence from the 5’ terminus of CVB3-CKO by
day 5 post-electroporation and later (lane B8;9 [5 days post-electroporation], lane
B11;12 [6 days post-electroporation], lane C2;3 [7 days post-electroporation] and lanes
C5;6 and C8;9 [2 different virus preparations at day 8 post-electroporation) as
compared to wt virus and T7 transcript controls (left facing arrows, lanes C11;12 [wt]
and D11;12 [T7 transcript]) or to CVB3-CKO at days 1 and 3 post-electroporation (left
facing arrows, lanes B2;3 [1 day post-electroporation] and B5;6 [3 days postelectroporation]. However, CVB3-CKO virus could be detected in all virus preparations
by RT-PCR priming in a region of the 5’ NTR not found to delete (compare lanes B4
[CVB3-CKO 1 day post –electroporation], B7 [CVB3-CKO day 3], B10 [CVB3-CKO day
5], B13 [CVB3-CKO day 6], C4 [CVB3-CKO day 7], C7 [CVB3-CKO day 8 preparation
1], and C10 [CVB3-CKO day 8 preparation 2] to lanes C13 [wt virus control] and D13
[T7 transcript control]). Controls (lanes C2-4, no cDNA PCR controls, lanes C5-7 no
template RT-PCR controls, lanes C8-10 tissue culture controls) were negative.
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transcript control (compare left facing arrows Fig. 10B lane 2 [1 day] and Fig. 10B
lane 5 [3 days] to Fig. 10C lane 11 [wt virus] and Fig. 10D lane 11 [T7 transcript
control]) and from nucleotides 15-15 (arrows Fig. 10B lane 3 [1 day] and Fig. 10B
lane 6 [3 days] to Fig. 10C lane 12 [wt virus] and Fig. 10D lane 12 [T7 transcript
control] as expected. However, by day 5 post-transfection and later, the CVB3-CKO
population has evolved to a TD population (compare Fig. 10B lanes 8 and 9 [5 days],
Fig. 10B lanes 11 and 12 [6 days], Fig. 10C lanes 2 and 3 [7 days], Fig. 10C lanes 5
and 6 [8 days preparation 1], and Fig. 10C lanes 8 and 9 [8 days preparation 2] to
Fig. 10B lanes 2 and 3 [1 day], Fig. 10B lanes 5 and 6 [3 days], Fig. 10C lanes 11
and 12 [wt virus], and Fig. 10D lanes 11 and 12 [T7 transcript control]) with the
expected wt band no longer detectable. That virus was present in all RNA preparations,
was verified using primers that anneal in a region of the 5’ NTR that has not been found
to delete, even when the 5’ genomic terminus was not detected, using nested RT-PCR
for detection of viral RNA in virus preparations (compare Fig. 10B lane 4 [1 day], Fig.
10B lane 7 [3 days], Fig. 10B lane 10 [5 days], Fig. 10B lane 13 [6 days], Fig. 10C
lane 4 [7 days], Fig. 10C lane 7 [8 days preparation 1], Fig. 10C lane 10 [8 days
preparation 2], and Fig. 10C lane 13 [wt] to Fig. 10D lane 13 [T7 transcript control]).
When compared to sequencing data (Fig. 7), these results show that 5’ TDs are
occurring prior to detection of complete reversion of the CRE(2C) to that of a wt
sequence (compare Fig. 10 demonstrating loss of 5’ genomic terminus between
days 3 and 5 post-electroporation [Fig. 10B lanes 5 and 6; Fig. 10B lanes 8 and 9
respectively] to Fig. 7 demonstrating that at 5 days post-electroporation the
majority population remains a CKO population [Fig. 7 row 7]).
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Discussion

The results described above present a surprising finding that was not expected
when this work began: all 16 mutations introduced in the CVB3 CRE(2C) region
(CVB3-CKO), revert completely to the wt sequence after a relatively short time of
replication in HeLa cells. These reversions from the mutated CRE(2C) (CKO) to the wt
CRE(2C) sequence could occur, at least in part, after several rounds of replication due
to a high selective pressure on the structure in the full-length genome (CVB3-CKO); this
would be due to the requirement of uridylylated VPg for replication of said full-length
genome. However, from previous work (chapter 2), we know that by 8 days postelectroporation in HeLa cells, the majority CVB3-CKO population has developed into a
TD population, and so reversions related to the requirement for VPg uridylylation are
unlikely. The reason for this is that it has been demonstrated that while the CVB-TD still
have VPg covalently linked to the 5’ genomic terminus, these viruses can terminate in
dinucleotides other than the canonical UU donated by VPg, suggesting that uridylylation
of VPg is not occurring (10) or if it is, it is inefficient. Further, work has demonstrated
that CVB-TD do not uridylylate VPg at detectable levels in cell free systems (J. B.
Flanegan, personal communication). This finding further supports the hypothesis that
CRE(2C) mediated uridylylation of VPg is not required by CVB-TD populations, and
suggests that VPg is nucleotidylated either in-situ during replication of CVB-TD viruses,
or is variably nucleotidylated at low levels using alternative templates. Cumulatively,
these results suggest that selective pressure driving the complete reversion in the
CRE(2C) sequence is likely related to another, and as yet undetermined, function of this
structure in the life-cycle of TD viruses. The finding that the CRE(2C) reverts to a wt
sequence in CVB3-TD50CKO after as few as 8 days of replication in HeLa cells (Fig. 7A row 12), further supports the likelihood of other functions for this structure.
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While it is difficult to accept that 16 mutations could suddenly revert en masse,
the process must be understood as a kinetic process, not a sudden accretion of
reversions (31, 102, 104, 105). The reversion of the 16 sites is extremely unlikely to be
a saltatory jump but one that must occur over time, "suddenly" appearing (on day 8 postelectroporation) when one of the outliers in the quasispecies cloud of mutants attains
complete reversion: at that point, it can replicate more rapidly than the others and so
becomes the new master sequence. Several reports have demonstrated rapid mutation
and reversion rates of RNA viruses in diverse environments. De la Torre and colleagues
demonstrated that as many as 5 mutations introduced into the 3AB domain of poliovirus
rapidly and completed reverted, after 5 days of incubation in HeLa cell culture, with no
detection of intermediate populations in sequence space, a finding that could not be
sufficiently explained at the time (43). Earlier work also demonstrated rapid reversion of
single-nucleotide mutations in the 2C coding region which had caused guanidineresistance in poliovirus, leading to a wt guanidine-sensitive phenotype in HeLa cells (44).
Mutations in other RNA viruses have also been demonstrated to revert in various
environments. Human immunodeficiency virus, though replicating differently than other
RNA viruses via a DNA intermediate, was reported to revert (from a drug-resistant
phenotype) a total of 52 mutations found in the reverse transcriptase and protease
genes after a period of 50 days in infected persons undergoing therapy with drugs
unrelated to those which induced the mutations (106). Another report demonstrated
reversion to a consensus sequence in structurally conserved regions of HIV that was
apparently more rapid than the forward mutation rate observed during chronic infection,
occurring at an average of 1.2% per year (reversions) compared to 0.2% per year during
the chronic stage of infection (forward mutations) (41). Interestingly, even in a very
small RNA plant viroid (359nt; potato tuber spindle viroid), induced mutations that
affected base pairing in hairpin structures found in the circular genomic molecule rapidly
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reverted to wt after a single passage in the host (107). While likely a different
mechanism than in RNA viruses, even a small DNA bacteriophage with a much less
error prone replication than RNA viruses, due to the intrinsic exonuclease activity of DNA
polymerases, has the capacity to naturally accrue as many as 14 mutations overall in a
period of 10 days in bacterial culture (108). Together, these findings are consistent with,
and support the validity of, our observation of rapid reversion of the 16 mutations
introduced into the CRE(2C) of CVB3 which, when present, greatly decrease viral
replication compared to wt (chapter 2).
Prior to our work (chapter 2), mutational disruption of the CRE(2C) was
considered lethal for an HEV. In work done by van Ooij and colleagues exploring
mutational disruption of the CRE(2C) of CVB3, both single and multiple mutations
introduced in the CRE(2C) region of the genome deleteriously affected important
aspects of viral replication (24). Mutations made in the loop of the CRE(2C) led in large
part to a loss of detection of VPg uridylylation using autoradiographic assays and,
further, led to a loss of luciferase activity in the construct used to explore the effect of
these mutations (24); exceptions to this were changes to U8 and A14 (counting around
the [CRE(2C)] loop from left to right [see Fig. 6]), suggesting that any mutations made in
the CRE(2C) which affected function were lethal. Important to note is that the mutations
assayed in these studies were not mutations that were part of the 16 nucleotide changes
used in our experiments (reported here or in chapter 2) or by van Ooij and colleagues
(24) when studying replication of CVB3 with a completely disrupted CRE(2C). Finally,
work examining complete disruption of the predicted CRE(2C) secondary structure
demonstrated that negative strand synthesis was occurring as evidenced by detection of
double-stranded RNA (replicative form; RF) on autoradiographic assays from cell free
systems (24, 29, 45). An altered positive to negative strand ratio during the replication of
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mutant viruses was observed with the CVB-TD (10) and found to occur in CVB3-CKO
(chapter 2). In a cell- free system, which lacks the natural and complete
compartmentalization that occurs during viral replication in cells, this would generate
equivalent amounts of positive (genomic) and negative (replicative intermediate) strand
RNA leading to detection of only RF. This was not observed (24, 45) with wt replication
in these systems due to the highly efficient transcription of positive strand RNA as would
be expected. Despite the conclusions that CRE(2C) mutations were lethal (24), we
suspect that replication was in fact occurring in CRE(2C) mutants studied in the cell free
systems, and combined with our data demonstrating that CVB3-CKO is replication
competent (chapter 2), would support our finding reported here that reversions are
possible.
Others have explored the effects of mutational disruption of the CRE(2C) (19, 24,
74). For example, it has been demonstrated that individual, or few, mutations introduced
into the loop of the CRE(2C) lead to a dominant negative effect, or cause a greater
defect in either positive or negative strand synthesis, than do multiple mutations
introduced into both the loop and stem. Goodfellow and colleagues demonstrated that
mutating the loop of the CRE(2C) in poliovirus using either one synonymous mutation in
varying locations, or 8 simultaneous mutations throughout the loop, led to loss of CPE in
transfected HeLa cells (19). These mutations led to inhibition of viral replication based
on autoradiographic assays, but CRE(2C) function could be rescued in cis by relocating
an unaltered, wt CRE to the P1 region of the genome (19). Despite the negative effects
observed, these studies also demonstrated that reversions were occurring in constructs
containing 2 or 3 mutations in the loop of CRE(2C), with recovery of CPE after a single
passage (2 mutations) or three blind passages (3 mutations) in HeLa cells (19).
Sequence analysis conducted by Goodfellow and colleagues found sequence
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conservation in the CRE(2C) to be significantly higher than would otherwise be expected
(19), an important point suggesting that the virus jealously guards the sanctity of the wt
sequence. Other studies conducted by Crowder and Kirkegaard found that two
synonymous double mutations within the loop of the CRE(2C) of poliovirus led to a
severe defect in viral replication, as indicated by the decrease or absence of plaque
formation by mutant viruses (74); this work also demonstrated that these double mutants
had a dominant negative effect, inhibiting wt poliovirus replication in co-transfected cells,
suggesting that the CRE(2C), even with mutations in the loop, binds proteins required for
viral replication (74). Importantly, when the CRE(2C) was disrupted entirely using 8
synonymous mutations throughout the stem and loop, no dominant negative effects
were observed (74). Based on these studies, it becomes clear why it is unlikely that we
see only single-base revertants in the CRE(2C) during sequence analysis, as, though
reversion is stepwise in the absence of recombination, these mutants would be rapidly
outcompeted by more fit replicons. Taken together, these data clearly indicate that the
CRE(2C) structure is intimately linked to viral replication, possibly with functions outside
that of uridylylation. A putative multi-functional CRE(2C) sequence that is required by
the virus, such as we propose here, may be why we do not see fewer reversions
occurring but rather a complete reversion to wt the sequence.
The analysis of sequences in GenBank to explore the possibility of compensatory
mutations within the stem of the CRE(2C), strongly suggests that it is unlikely for
compensatory mutations to occur (Fig. 9), because any compensatory mutations in the
region of the CRE(2C) would alter the amino acid sequence of the corresponding 2C
protein. Further, all identified CRE structures within picornavirus genomes have a highly
conserved stem structure (16, 18, 19, 22, 24) suggesting that compensatory mutations
deviating from this should not occur. Of the possible compensatory mutations which
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could occur due to base-pairing, only one has been reported, albeit rarely (1 in 429
sequences) in NCBI data bank, leading to an E121K change. This suggests that any
other changes to the 2C protein are lethal mutations in the CVB population. Further
work to explore this hypothesis is therefore warranted. Compensatory mutations in the
loop of the CRE(2C) should also be very unlikely, as point-mutational analysis done by
others demonstrated that single-nucleotide changes in the loop of the CRE(2C) inhibited
the synthesis of the negative strand intermediate, and VPg uridylylation, while those in
the stem did not (24). Further, it has been demonstrated that double-base changes in
the loop of the structure are also highly deleterious to viral replication (as discussed
above). These findings, coupled with the fact that the CRE(2C) is in a protein coding
region, should prevent compensatory mutations that inhibit the function of the loop, or
that alter the amino-acid sequence of the 2C protein. Because the bases in the loop
region of the CRE(2C) structure are not expected to participate in base-pairing, we were
unable to asses if compensatory mutations could occur. However, based on the
absence of sequence variation in 35 random EV-B CRE(2C) loop sequences found in
GenBank (data not shown), it is unlikely that deviations from the wt CVB3 CRE(2C) loop
sequence would occur.
In entertaining other possibilities as to why wt sequence was detected in our
sequencing assays, we concluded that contamination with wt RNA could be ruled out.
This was based on transfection experiments in which few copies of wt CVB3 T7
transcribed RNA (from 10-1,000 copies) were transfected with a constant and higher
concentration of CVB3-CKO T7 RNA (1.97x1011 copies). Even when as few as 10
copies of wt RNA were present, wt virus replicated and produced detectable CPE on
blind passage in HeLa cells (Table 3). Importantly, we never saw CPE even after three
passages of purified CVB3-CKO virus in cell culture, indicating contamination with wt
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CVB3 had not occurred. Further, subcloning and sequencing of 32 clones of the
CRE(2C) sequence, prepared from four different CVB3-CKO purified virus preparations
(8 clones each), demonstrated that all clones were of wt sequence (data not shown).
This would be statistically impossible were contamination to have been a factor. Finally,
we conclude from sequencing controls in which 2-fold increases of wt CVB3 cDNA clone
were mixed with a constant concentration of CVB3-CKO clone, that with as low a ratio
as 4:1 wt:CVB3-CKO, we would only detect wt sequence (Fig. 8). This suggested that
during reversion only a 4:1 virus ratio would be required of the more efficiently replicating
virus to completely mask the CKO mutants.
Of the discussed possibilities for complete reversion to occur, it is likely that
reversions take place over time with those changes that led to decreased viral fitness
being out competed. Standard Sanger sequence analysis being an inefficient detection
assay, such changes are masked until the new master (wt) sequence is regenerated,
whereupon it becomes the dominant (detectable) sequence, completely outcompeting
viral genomes with mutations in the CRE(2C). It can also be expected that in some
genomes, more than one reversion occurs at a time and, through events such as
recombination between two partially reverted genomes, the wt sequence could
eventually be recovered. When the wt sequence is regenerated, it rapidly dominates the
population, with the CKO population collapsing and disappearing from detection. It can
be concluded from the findings of others, as discussed above, that single base
reversions would be less likely to replicate well when compared to multiple reversions,
as they are more detrimental to viral replication than are larger numbers of mutations
throughout the stem and loop of CRE(2C), having a dominant negative effect on other
viruses replicating in the same cell (74). Therefore, it is highly unlikely that the observed
16nt reversion is an event re-creating the wt sequence. Far more likely is the gaining
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over time of the correct changes, none of which alone would reconstitute function or
structure, but would lead to it. As the viral population approached complete reversion,
mimicking the lesser number of mutations made by others that slowed but did not
eliminate replication, the reversions would eventually lead to a complete wt CRE(2C)
and rapid re-ascendance of this more efficiently replicating population. Future work will
be important to determine at what point reversion actually does occur during the
replication of the CKO viruses. Because these viruses replicate at approximately
100,000-fold lower levels than wt, a large number of purified virus preparations will be
required to generate enough RNA for methods such as deep sequencing or RNA-Seq.
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Chapter 4

A novel, broadly applicable approach to isolation of fungi in diverse growth
media. 2

Introduction

There is a need for different and selective media for the propagation and isolation
of fungi for identification in clinical settings and for the detection of fungal presence in the
environment [14, 16, 17, 20]. The isolation of both yeasts and molds (i.e., fungi) from
clinical and environmental samples can be complicated by various factors. Fungal
growth in clinical or environmental samples may often be inhibited due increased growth
rates of bacteria as well as bacterial production of deleterious metabolites. These
factors can result in failure to detect fungi in mixed cultures (109, 110). Additionally,
fungi often have diverse and specific nutritional requirements which may limit the extent
and robustness of the growth of a given organism in the absence of a specific nutrient
(49, 54). Sabouraud dextrose agar (SDA), originally defined by Raymond Sabouraud in
the late 1800s, remains the medium of choice for the isolation of fungi (50, 52).
Sabouraud's formula, a basic glucose and peptone formulation adjusted to a pH of 5.6,
uses the lower pH as the inhibitory growth factor for bacteria. Selective media such as
SDA are used when a need exists to isolate fungi from mixed cultures containing
bacteria. However, SDA does not inhibit all bacterial outgrowth: one study reported that
in mixed clinical cultures containing both bacteria and yeast, yeast were detected on
2

The work presented in this chapter was previously published: Shane Smithee, Steven Tracy,
Kristen Drescher, Lisa Pitz, and Thomas McDonald; A novel, broadly applicable approach to the
isolation of fungi in diverse growth media, Journal of Microbiological Methods, 2014, 105:155161. License for reuse granted by Elsevier 05.28.2015: 3637740371246.
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SDA in only 77% of samples tested while others were obscured by bacterial growth (52).
Further, selective media like SDA may not provide the necessary nutrients or be the
most optimal media for isolation of all types of fungi from either clinical or environmental
samples [3, 5, 15-18]. For example, when comparing SDA to other media, one study
demonstrated that, in general, fungi associated with fungal keratitis grew more rapidly,
and were detected more frequently, on media such as blood agar and chocolate agar
versus SDA (48); this suggested that SDA did not provide optimal nutrients and growth
requirements for these fungi. While this is not a universal finding (111), sufficient
concern exists to identify a more efficient selective media than SDA.
The efficiency with which SDA functions for the isolation of fungi has been
compared to other fungus identification media that employ antibiotics to suppress
bacterial outgrowth. For example, after inoculation with clinical mixed cultures, more
fungal isolates were propagated on inhibitory mold agar, a complex media containing
chloramphenicol, than on SDA, although some genera were propagated only on SDA
(53). Compared to modified Pagano-Levin agar (MPL) which contains both gentamicin
and triphenyltetrazolium chloride, MPL proved to be more effective than SDA at isolating
different yeast species from oral samples (51). It is important to note that the addition of
antibiotics such as chloramphenicol to growth media may also adversely affect the
growth of certain fungal species (112, 113). Other reports have explored chemically
augmented SDA formulations to increase fungal isolation specificity. For example, the
addition of gallium (III) nitrate to SDA effectively inhibited bacterial growth, although at
concentrations greater than 16mM, gallium (III) nitrate also inhibited the growth of fungi
as well as bacteria (114). Although these approaches are useful, they involve modifying
different media with diverse reagents which increase costs for laboratories (53) in
addition to increasing the difficulty in standardization of testing systems in clinical
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settings. The various formulations of SDA can also limit the type of media on which
specific or new fungi might best be propagated. The ideal reagent would be one that, if
added to any growth medium, could function for the isolation of fungi while efficiently
suppressing all bacterial outgrowths.
Creatinine (CRN) is a natural vertebrate metabolic waste product of the
breakdown of the high-energy compound creatine phosphate [16]. This primarily nonenzymatic reaction leads to a steady production of CRN in the body which is
subsequently voided in urine; CRN is considered to have no biological function [16].
However, our previous work demonstrated that the addition of the protonated form of
creatinine [creatinine hydrochloride (CRN-HCl)] to growth media inhibits bacterial growth
without affecting the outgrowth of fungi, even at concentrations greater than 200mM
(47). The mechanism by which CRN-HCl selectively inhibits prokaryotes has not been
elucidated, although it may overwhelm efflux pumps, causing an accretion of protons in
bacterial cells, thereby lowering intracellular pH and disrupting metabolic pathways (47).
Although the anhydrous form of CRN does not inhibit bacterial growth, the protonated
form in either a hydrochloride or other salt, is highly effective as an antibacterial agent
(47). Because of its demonstrated ability to inhibit bacterial replication and to kill
bacteria, we tested the hypothesis that the addition of CRN-HCl to different solid and
liquid media will facilitate isolation of fungi while completely inhibiting bacterial
outgrowth.

Materials and Methods
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Microbial strains and culture conditions. Two bacteria and two yeast strains were
used in this study: Staphylococcus aureus (ATCC 29213, Manassas, VA, USA),
Escherichia coli strain DH5α, a strain commonly used for molecular cloning (Invitrogen;
Life Technologies, USA), Saccharomyces cerevisiae (common baker’s yeast), and
Rhodotorula mucilaginosa (an environmental isolate). Genus and species of
microorganisms were verified as described below in enzymatic amplification of rRNA
sequences. All microorganisms were grown routinely for 18 hours at 32°C shaking at
300 RPM in 100 mL cultures of LBG [Luria broth (LB; Amresco, Solon, OH, USA)
supplemented with 1% w/v D-glucose (Fisher Scientific; Fair Lawn, NJ)]. Cultures were
maintained on LBG agar. Cultures were individually prepared by inoculation with a
single colony of each respective microorganism. Organism concentrations were
determined by serial dilution and plating on LBG agar to determine counts of colonyforming units (cfu) per mL prior to subsequent experimentation.

Enzymatic amplification of rRNA sequences for organism identification. Genus
and species were determined for microorganisms by amplifying the appropriate rRNA
sequence from chromosomal DNA. DNA was isolated from 2 mL cultures inoculated
originally with a single colony using the Zymo ZR Fungal/Bacterial DNA Miniprep Kit
(Zymo Research; Irvine, CA, USA) per manufacturer’s protocol. Primers specific to
bacterial 16S rRNA and fungal 18S rRNA are shown in Table 4 (primers specific to
fungal rRNA (1), primers specific to bacterial rRNA (2)). Twenty microliter (μL)
reactions were assembled with GoTaq Green Master Mix (Promega) with primers
included at a final concentration of 0.5 μM, then cycled in a TC-312 thermal cycler
(Techne; Duxford, Cambridge, UK) with the following conditions: initial denaturation for
5 min at 94°C followed by 20 cycles (16S primers) of 10 sec at 94°C, 20 sec at 39°C,
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Table 4. Primers used for sequencing of bacterial and fungal
specimens. a (1), b (2)

78
and 2 min at 72°C or 40 cycles (18S primers) of 10 sec at 94°C, 20 sec at 43°C and 2
min at 72°C, finishing with 5 min at 72°C. Ten microliters of the 20 μL PCR reactions
were analyzed on 1% agarose gels to verify successful amplification and expected size
of the amplimer (data not shown). The remainder of the reaction was ethanol
precipitated, resuspended in water, and submitted for sequence analysis at the UNMC
sequencing core facility. Sequences were analyzed with Nucleotide BLAST using the
National Center for Biotechnology Information (NCBI) GenBank.

Culture media. Liquid LBG was prepared as described previously (47) and as indicated
above. Nutrient agar was prepared by adding 1.5% (w/v) bacto agar (BD; Sparks, MD)
to liquid LBG prior to sterilization. Sabouraud dextrose agar (SDA) was prepared using
Sabouraud dextrose broth (Sigma Aldrich; St. Louis, MO) per manufacturer’s
recommendations with 1.5% w/v bacto agar. Agar media containing 100 mM CRN-HCl
was prepared by first cooling liquid agar medium in a water bath to 56°C, to which CRNHCl (F.W. 149.6; Sigma-Aldrich St. Louis, MO, USA) was then added. Adding CRN-HCl
to agar media prior to sterilization prevents cross-linking and solidification; after mixing to
solubilize CRN-HCl, plates were poured. LBG or SDA agar media containing antibiotics
were prepared by addition of a combined penicillin and streptomycin solution (Invitrogen)
to a final concentration of 100 I.U./mL and 100 μg/mL respectively, and ampicillin
solution (Fisher Bio Reagents) to a final concentration of 100 μg/mL with media below
56°C and immediately prior to pouring.

Measuring effects of CRN-HCl concentration on microorganism growth at varying
inocula. Single colonies were inoculated into 50 mL LBG cultures in 250 mL
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Erlenmeyer flasks and shaken overnight as described above. Absorbance at 600nm
was measured for each culture using a spectrophotometer and cfu/mL determined for
each culture (based on linear regression data constructed by plotting absorbance at
600nm against cfu/mL for each microorganism). A series of ten-fold dilutions were
performed in LBG for final concentrations of ca. 10³ - 107 cfu/mL of each microorganism.
Cultures in sterile 16x125 mm glass culture tubes were prepared in duplicate containing
4.25 mL of LBG, 250 μL CRN-HCl [at a concentration of 400 mM, 800 mM, 1.2 M, 1.6 M,
or 2 M, (water instead of CRN-HCl was used as the control)], and 500 μL of culture
dilution (at either 107, 105, or 103 cfu/mL). Cultures contained final concentrations of 20
mM, 40 mM, 60 mM, 80 mM, 100 mM or no CRN-HCl respectively, and 106, 104, or 102
cfu per mL respectively in total volumes of 5mL. Tubes were placed at a slant and
shaken at 300 RPM and 37°C for 18 hours. Following incubation, absorbances at
600nm were recorded, a series of tenfold dilutions of each culture in sterile water were
made and plated on LBG agar in duplicate. Agar plates were incubated overnight at
37°C (with the exception of R. mucilaginosa plates which were incubated at 25°C for 48
hours due to better growth at lower temperatures) and colonies counted to determine
counts of cfu/mL at each CRN-HCl concentration. These experiments were repeated
with n=4 culture tubes for each of the four microorganisms at each inoculum, and n=8
plates inoculated and counted for each microorganism.

Comparison of environmentally-obtained microbial growth on LBG and SDA agar.
Five grams of soil were shaken in 50 mL of sterile 1x phosphate buffered saline (PBS)
and allowed to settle for one hour. Fifty microliters of the supernatant were spread onto
agar plates containing LBG, LBG + 100 mM CRN-HCl (LBG-CRN), LBG + antibiotics,
SDA, SDA + 100 mM CRN-HCl (SDA-CRN), or SDA + antibiotics (prepared as
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described above). Plates were incubated at 37°C and images of microbial growth on the
plates were obtained at 24, 48, 72, and 96 hours post-plating using an AlphaImager HP
MultiImage II imager (Protein Simple/Alpha Innotech; Santa Clara, CA, USA). To
determine if the vigorous colonization observed at 24 hours on the SDA plate were
bacterial and not fungal, two colonies with differing morphologies were picked after 24
hours of growth, inoculated into 5mL of Sabouraud dextrose broth, and incubated 18
hours at 32°C/300RPM. Following incubation, cultures were collected by centrifugation
and DNA extracted as described above. Genus and species of microorganisms were
verified following traditional PCR and sequencing as described above using primers
specific to bacterial 16S ribosomal sequences as listed in Table 4. The bacteria were
determined to be Bacillus megatarium and Pasteurella pneumotropica based on BLAST
results using NCBI GenBank (results not shown). These experiments were done with
three different soil samples processed as above and plated on each of the four different
media described for n=3 of each plate type.

Comparison of common bacterial growth on LBG and SDA. Glycerol stocks of
either S. aureus or E. coli were streaked for isolation onto LBG plates and incubated
overnight at 37°C. A single colony from each plate was picked and streaked onto one
half of LBG, SDA, LBG-CRN, or SDA-CRN plates. Plates were incubated overnight at
37°C and subsequently observed for growth. These experiments were repeated for n=2
plates of each type streaked with both S. aureus and E.coli.

Isolation of an antibiotic-producing fungus using CRN-HCl. Individual fungal
colonies were selected from soil samples previously plated on LBG-CRN growth agar,
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transferred to individual LBG plates without CRN-HCl, and incubated at room
temperature; a total of greater than 50 fungi of varying morphologies were isolated.
Fungal isolates were plated on medium without CRN-HCl in order to ensure that
subsequent testing with bacteria could be accomplished. Fungal colonies were tested
for antibiotic production when colonies were 2-3 cm in diameter. Cultures of S. aureus,
E. coli, S. cerevisiae, and R. mucilaginosa to be used as the test target organisms were
diluted to approximately 1x104 cfu /mL. Using 25 μL drops, each culture was spotted
four times inward from the edge of the plate toward each fungal colony (termed "the
drop-test" method) and plates were incubated overnight at 37°C. Plates were
subsequently observed for microorganism growth and presence of zones of inhibition
indicating antibiotic production by the fungus. Antibiotic production by an environmental
fungal isolate is a representative of n=10 replicates.

Results

Effect of CRN-HCl on microbial growth in liquid media. We initially compared CRNHCl concentrations using the 4 organisms listed above (section 2.1.) to determine impact
upon growth. Cultures were inoculated with bacteria or yeast in various concentrations
of CRN-HCl and incubated overnight with shaking. After measuring absorbance at
600nm, ten-fold serial dilutions were performed and plated to determine cfu/mL present.
It is apparent that the growth of yeasts was uniform across the spectrum of CRN-HCl
concentrations (Fig. 11 A-C). There was no difference observed in the growth of either
yeast strain tested after 18 hours of incubation, confirming and extending similar results
observed previously using absorbance at 600nm as a measure of replication [10]. The
effects of the addition of CRN-HCl on bacterial growth varied depending upon the
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FIG. 11. Comparison of antibacterial effect of CRN-HCl at increasing
concentrations on microorganisms at decreasing inocula. Microorganisms (S.
aureus, E. coli, S. cerevisiae, or R. mucilaginosa) were inoculated at three different
concentrations into 5 mL cultures of LBG media containing increasing concentrations of
CRN-HCl and cfu/mL as described in Methods. Cultures were inoculated at two
different times in duplicate for n=4 tubes for each microorganism and inoculum size.
Each culture was plated in duplicate for n=8 plates counted to determine cfu/mL.
Inhibition of growth was observed in bacteria (E.coli and S. aureus) at increasing [CRNHCl] but not in fungi (S. cerevisiae and R. mucilaginosa) (A-C). Panel A shows results
for a 106 inoculum of each microorganism, panel B shows results for a 104 inoculum of
each microorganism, and panel C shows results for a 102 inoculum of each
microorganism.
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bacteria. For example, CRN-HCl was bacteriostatic (i.e. after overnight incubation,
approximately the same number of cfu/mL were present as were in the initial inoculum
indicating inhibition of replication) for S. aureus at 20 mM but not for E. coli.
Concentrations of 40-80 mM CRN-HCl were bacteriostatic to E. coli but bactericidal (i.e.
after overnight incubation, fewer cfu/mL were present than were in the initial inoculum
indicating cell death) to S. aureus. Concentrations of 100 mM CRN-HCl were
bactericidal to both S. aureus and E. coli (results were consistent when comparing
absorbance at 600nm; data not shown and (47)). Although S. aureus appeared to be
more sensitive than E. coli to CRN-HCl overall (based on the CRN-HCl concentration
required to reduce titer as measured by cfu/mL), there was no significant difference
when analyzed using a two-tailed student t-test (p=0.8788 106 inoculum; p=0.7620 104
inoculum; p=0.8027 10² inoculum).

Supplementation of diverse agar media with CRN-HCl. Having shown that E. coli
and S. aureus were killed in the presence of 100 mM CRN-HCl while fungi were
unaffected in growth, we then asked whether similar results would be obtained using
environmental samples containing a diverse population and unknown titer of
microorganisms. Soil samples were therefore suspended in 1x PBS, spread onto LBG,
LBG-CRN and LBG+antibiotic plates, incubated over a period of days, and observed for
growth as described in section 2.5. above. Robust bacterial growth was observed within
24 hours of inoculation on the LBG plates containing no selective reagents (Fig. 12, A1). In sharp contrast, no growth was observed at 24 hours post inoculation on LBG-CRN
plates (Fig. 12, A-3) nor was growth observed on antibiotic containing LBG plates
(Fig.12, A-2), confirming that CRN-HCl is as effective at suppressing growth of diverse,
unknown bacterial species as an antibiotic cocktail. Growth on plates not containing
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FIG. 12. Comparison of CRN-HCl and antibiotic supplemented LBG to SDA for
enhancement of fungal growth from environmental (soil) samples. Plates were
inoculated with soil samples suspended in 1x PBS prior to incubation. Three different
soil samples were tested on each of the media described in methods for n=3 plates of
each type inoculated. Rows A-D, columns 1-3, show LBG plates either without
addition of antibiotics or CRN (row 1), with the addition of antibiotics (row 2), or with
the addition of 100 mM CRN-HCl (row 3). Rows A-D, columns 4-6, show SDA plates
either without addition of antibiotics or CRN (row 4), with the addition of antibiotics
(row 5), or with the addition of 100 mM CRN-HCl (row 6). Images were taken of
plates at 24, 48, 72, and 96 hours after incubation at 370 C.

85
selective reagents was confirmed as bacterial by sequence analysis as described in
Methods (data not shown). Similar results showing bacterial inhibition were also
observed on both brain heart infusion plates and LBG plates containing 1% potato starch
(data not shown). At 48 hours post inoculation, fungal colonies were observed on both
LBG-CRN plates and LBG+antibiotic plates (comparing Fig. 12, B-3 and B-2
respectively). In several similar experiments, there was no significant difference
between fungal outgrowth rates on antibiotic versus CRN-HCl plates when analyzed
using a two-tailed student t-test (p=0.4885). No apparent fungal growth was observed
on LBG plates without addition of selective reagents, likely due to rapid outgrowth of
bacteria (bacterial colonies observed at 24 hours increased in size throughout the time
course) (Fig. 12 column 1); however, we did not assay the mixed population by
sequence analysis for the presence of eukaryotic rRNA sequences.

Comparison of fungal and bacterial outgrowth on Sabourad's agar with and
without CRN-HCl to LBG and LBG-CRN inoculated with soil supernatants.
Sabourad's medium is used routinely to suppress the outgrowth of bacteria while
isolating fungal specimens. To compare this selective medium with the bacteriostatic
effect of CRN-HCl, we compared SDA to LBG with and without 100 mM CRN-HCl or
antibiotics as a supplement. We inoculated the four different media with supernatants of
soil samples as described above. Robust microbial growth was present on the SDA
plates containing no selective reagents, similar to results observed on LBG plates
(comparing Fig 12, A-1 and A-4 respectively). In contrast, and again as observed
with LBG at 24 hours post inoculation, growth was observed neither on SDA-CRN plates
(Fig 12, A-6) nor on SDA plates containing antibiotics (Fig 12, A-5). By 48 hours post
inoculation, fungal colonies were present on both SDA-CRN plates (Fig 12, B-6) and
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SDA+antibiotic plates (Fig. 12, B-5) similar to that observed for LBG plates containing
either CRN-HCl or antibiotics. Further, and of potential clinical importance, S. aureus
and E. coli were able to grow apparently as well on SDA as on LBG plates after 24 hours
of incubation at 37° C (Fig. 13A). However, addition of CRN-HCl to these media
effectively suppressed the growth of these bacteria (Fig. 13B).

Using CRN-HCl to isolate antibiotic producing fungi. The observation that media
which contained CRN-HCl completely suppressed bacterial replication suggested to us
that one application of this finding would be as an approach to facilitate new antibiotic
discovery. We tested this hypothesis by screening environmental soil samples for fungi
that produced anti-bacterial activity. Fungal colonies grown on various agar media
containing 100 mM CRN-HCl were picked and transferred to LBG for growth in the
absence of CRN-HCl. When fungal colonies were between 2-3cm in diameter, the two
bacteria and two yeasts used for this study were prepared and spotted from the edge of
the plate inward toward each fungal colony. Plates were incubated overnight as
described in methods. Several hundred phenotypically different fungi were isolated, and
then tested, in this manner for production of antibiotic activity against the two bacterial
species and the two yeast species used in this project. This 'drop test' approach is
diagrammed in Fig. 14A. No antibiotic activity (graded as number 1) is represented by
each drop actively growing up to the fungal colony. Gradations of antibiotic output are
signified by numbers 2-5 where number 5 represents the largest zone of inhibition
produced by antibiotic output into the agar. Results from one fungal isolate that showed
antibiotic activity is shown in Fig. 14B, C. There is clear inhibition of growth of the two
bacterial species (graded as a 4 for significant antibiotic activity against both S. aureus
and E. coli), but not the yeast species (graded as a 1 for no activity). Figure 14C shows
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FIG. 13. Comparison of common bacterial growth on LBG and SDA. LBG and
SDA (A; left and right respectively) and LBG-CRN and SDA-CRN (B; left and right
respectively) were streaked with single colonies of S. aureus (left half of plates) and
E. coli (right half of plates) then incubated overnight at 37⁰ C.
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FIG. 14. A method for identification of antibiotic producing fungi using
CRN-HCl for initial fungal isolation. To demonstrate one use for CRN-HCl
addition to media, fungi were picked from LBG-CRN plates (greater than 50
fungal colonies of varying morphologies), plated on LBG, and allowed to grow.
Cultures of target organisms (S. aureus, E. coli, S. cerevisiae, or R.
mucilaginosa) were diluted to approximately 1x104 cfu /mL (in 25μL per drop)
were then dropped inward from the edge of the plate toward the fungus and
allowed to incubate (termed the “drop test” method). Panel A illustrates the
“drop test” method with varying zones of inhibition (1 = no inhibition; 2 and 3 =
mild inhibition; 4 and 5 = high inhibition). Panel B shows the results from one
fungal isolate that showed antibiotic active (a representative of n=10
replicates). Panel C shows an expanded view of the plate in panel B with
arrows indicating zones of inhibition due to antibiotic production.
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an enlargement of the inhibition zone against the Gram negative and Gram positive
bacterial species. Although yeast growth was not inhibited, a slight negative effect on
colony size at the fungal interface was noted which was attributed to nutrient
competition, or other metabolic conditions, but was not considered anti-fungal activity.
This fungus was submitted for sequence analysis and was identified as a Penicillium
genus with the closest species association being pupurogenum based on 18S rRNA
analysis. BLAST data (NCBI GenBank) gave an E-value of 0.0 which indicates a
significant match for this organism.

Discussion

Routine isolation of fungi from mixed samples can be complicated by a variety of
factors; most commonly, fungal growth may be inhibited by bacteria (109, 110) or
altered/inhibited by diverse and specific nutritional requirements (49, 54). There is a
need for an agent that can be added to different and selective media for the propagation
and isolation of fungi (52, 53, 111, 115) without the need for antibiotics. We
demonstrate here that CRN-HCl is an alternative and cost-effective approach for the
isolation of fungi in diverse media. On average, antibiotics cost between $1-60 per gram
(streptomycin and gentamicin, respectively) whereas the cost of CRN-HCl obtained
commercially for laboratory use is on the order of $0.50 per gram (Sigma Aldrich; St.
Louis, MO). The addition of antibiotics to media can also adversely affect the growth of
certain fungal species (112, 113). Previous work which demonstrated that the
mechanism of bacterial killing by CRN-HCl was not due to decreased pH (47) led us to
compare SDA to media supplemented with CRN-HCl. While SDA and CRN-HCl
supplemented media function at a pH of 5-5.5, only media containing CRN-HCl kills
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bacteria and completely suppresses bacterial replication while permitting fungal
outgrowth.
The persistent value of SDA has been that it tends to inhibit bacterial growth
while allowing fungal outgrowth but it has been noted that this selective medium is not as
efficient as might be desired (48, 51-53, 114). Our data show that SDA failed to
efficiently inhibit diverse bacterial growth compared to other media (Fig. 12 and Fig. 13)
regardless of whether laboratory bacterial strains or, more convincingly, numerous
unknown environmental species were tested. These results confirm and greatly extend
previously published data (47) demonstrating the use of CRN-HCl in media as an
effective means to suppress bacteria while allowing for the outgrowth of slower growing
fungi. In this report, we screened diverse soil samples for fungi that might produce
antibiotic-like activities to test whether CRN-HCl could function in a model more relevant
to the goal of discovering new antibiotics. These results demonstrated that CRN-HCl is
highly effective at suppressing the rampant outgrowth of diverse bacterial species found
in the environment while permitting fungal outgrowth. Using this approach, several fungi
were isolated that express an antibacterial activity (data not shown). This is an
important point as many fungi grow much more slowly than bacteria [8, 13, 24]. Again,
the need to screen numerous isolates for antibiotic activity accentuates the benefit of
using low-cost CRN-HCl as the antibacterial in such tests. The use of CRN-HCl as an
antibacterial agent should also be applicable to mixed clinical samples in which it is of
interest to determine whether (slow growing) pathogenic fungi are involved in a disease
course.
Creatinine hydrochloride has been shown to dramatically suppress bacterial
growth. The addition of this inexpensive, readily available compound to several media
demonstrated that while bacterial replication was ablated, fungal growth occurred similar
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to growth on control media without CRN-HCl. Slow growing fungi can therefore be
isolated without having first to remove associated bacterial populations and without any
overgrowth of bacteria. Using a straightforward "drop test" to assay fungi isolated on
CRN-HCl media, one can quickly determine whether the fungal isolate shows antibiotic
activity. This assay could, if desired, be automated. Because fungi have notably
different preferences for growth media (49, 54), results reported here importantly
suggest the potential for the use of creatinine salts in diverse media that favor diverse
fungal outgrowth. Protonated CRN should serve as a useful tool in the search for new
antibiotics to address the growing problem of commonly encountered antibiotic resistant
bacteria especially in clinical settings (116-119).
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Chapter 5

Conclusions from the Characterization of the Replication of Coxsackievirus B3
with a Mutationally Disrupted CRE(2C) and the Use of Creatinine-hydrochloride as
an Antibacterial Agent.

Chapters 2 and 3 of this dissertation describe novel, important, and heretofore
unsuspected facets of HEV biology. As described in detail in the pages of this work,
previous work in this laboratory demonstrated that the CVB persist in tissues and in cells
after deletion of sequence from the 5’ genomic terminus, a natural mechanism, leading
to loss of much of domain I (9, 10, 13). Though these results contributed significantly to
the field, little is still known about how the CVB-TD viruses initiate replication. Based on
these previous findings which demonstrated that the CVB-TD rarely terminated in the
canonical UU found at the 5’ end of the wt virus (donated by uridylylated VPg after
initiation of replication) but still had VPg attached, and packaged negative strand RNA (a
replication intermediate) at a near 1:1 ratio with the (positive strand) genomic RNA (10),
we hypothesized that the CVB-TD did not require a functional CRE(2C) in order to
replicate. Mutational analysis by others had demonstrated that when the CRE(2C) [a
structure and template for the uridylylation of VPg (14, 27)] of either poliovirus or CVB3
was disrupted by engineering in silent mutations, important steps in the replication of
these viruses was affected: uridylylation of VPg did not occur to detectable levels using
autoradiographic assays and positive strand synthesis was inhibited when compared to
negative strand synthesis (24, 27, 45, 75). The combination of these findings led to the
conclusion that without a functional (which is to say, uridylylating) CRE(2C), the HEV
could not replicate (i.e., disruption of the [CRE(2C)] was lethal).
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Based on previous findings regarding the CVB-TD (9, 10, 13), and the findings of
others regarding the CRE(2C) (24, 27, 45, 75), we introduced 16 mutations (24) in the
region of the genome corresponding to the CRE(2C) of both CVB3-TD50 (CVB3-TD50CKO) and wt CVB3 (CVB3-CKO; intended to be a negative replication control) to study
the effects of mutational disruption of this structure on CVB-TD replication. These 16
mutations had been stated to be lethal in the CVB3 genome (24, 45). Because our
preliminary data demonstrated, surprisingly and in counterpoint to others' findings (24,
27, 45), that CVB3-CKO in fact was replication competent, we examined the replication
and evolution of the CVB3 viruses in which the structure of the CRE(2C) had been
altered using wt CVB3 and CVB3-TD50 as positive controls for replication. The
experiments outlined in chapter 2 of this dissertation illustrated the replication efficiency
of the CVB3-CKO, demonstrating that these viruses replicated at near equal levels when
compared to the CVB3-TD50 and CVB3-TD50-CKO virus populations. As a whole, the
mutant viruses replicated at approximately 5 logs lower efficiency by day 8 post
electroporation when compared to wt CVB3, but when compared to each other, were not
significantly different (Fig. 2). This demonstrated that loss of a functional CRE(2C)
affected the replication of wt CVB3 as much as loss of much of domain I, and supported
the hypothesis that the CVB-TD viruses did not require a functional CRE(2C) for
replication.
The observation that CVB3-CKO replicated at near equal efficiency to CVB3TD50 and CVB3-TD50-CKO, coupled with the absence of observable CPE in cells
electroporated or inoculated with this virus, suggested that loss of 5’ genomic terminal
sequence was occurring and that a population of TD viruses was evolving in cells
electroporated with CVB3-CKO RNA. To confirm this, tagged primers [(78); Table 1, 2]
were used to detect small deletions at the 5’ genomic terminus. Indeed, when compared
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to T7 transcript or wt CVB3 viral RNA controls, the majority CVB3-CKO population had
evolved 5’ TDs by day 8 post electroporation (Fig. 3). This demonstrated that when the
CRE(2C) function was lost in wt CVB3, a non-specific initiation of viral RNA replication
was occurring, generating a virus population that had lost 5’ terminal genomic sequence.
The experiments presented in chapter 2 also demonstrated that biophysically purified
virus preparations isolated from cell culture at 8 days post electroporation were
infectious as demonstrated by the ability to inhibit passage in the presence of anti-CVB3
neutralizing antibody (Fig. 4).
In an effort to demonstrate that the persistent replication of CVB3-CKO was not
an artifact observed only in cell culture, it was important to demonstrate that replication
of this virus was occurring in an animal model as well. In inoculated mice, many more
cell types are available for infection by a CVB. Because of the replication defect present
in the CVB3-CKO, it was difficult to acquire enough infectious virus to inoculate mice
and, therefore, an in vivo transfection model was developed that allowed us to inoculate
mice with T7 transcribed RNA of either CVB3-CKO or wt CVB3 (as a positive control).
Using this method, we were able to demonstrate that CVB3-CKO virus was detectable in
mouse tissues at day 20 post transfection and could be passaged in cell culture and
inhibited by neutralizing antibody; the same results were observed with wt CVB3
transfected mice (Fig. 5). Together, these data extended the results observed in cell
culture, and confirmed that a CVB could replicate in the absence of a functional
CRE(2C). Further, these experiments confirmed that transfection of mice with T7
transcribed CVB3 RNA was a useful method for studying wt CVB and those viruses
which replicate poorly in comparison (e.g., CVB3-CKO).
Further investigation of the mutations introduced into the CRE(2C) region of
CVB3-CKO during replication led to another surprising and again, unanticipated, finding:
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the introduced mutations had apparently completely reverted to the wt sequence in the
majority population by day 8 post electroporation in cell culture and when assayed at
day 20 post transfection in mouse tissues. In the experiments discussed in chapter 3 of
this dissertation, we explored the aspects of this reversion through sequence analysis,
as well as the relative point in time in which 5’ terminal deletions occur relative to the
CRE(2C) reversions. Initially, it was important to determine the ratio of wt to CKO at
which we would no longer observe the mutant sequence by nucleotide sequencing. In
analyzing sequences in which the ratio of wt:CKO increased by 2-fold to a final ratio of
8:1, we found that at a ratio as low as 4:1 or 8:1, we were no longer able to detect the 16
mutations that were introduced into the CRE(2C) region (Fig. 8). This was an important
control which demonstrated that if CVB3 replicated more efficiently than those viruses
which lacked a functional CRE(2C) in a mixed population, only a 4:1 ratio of revertants to
mutants was required to render the mutant sequence undetectable by traditional
sequencing techniques. Said differently, as long as a specific sequence did not exist at
least as much as 25% of the total, it would not be detected by standard Sanger
sequencing of the total population. This is entirely consistent with discussions of RNA
virus quasispecies populations in which a master sequence is that which is dominantly
detected, despite being surrounded by a 'swarm' of other sequences at lower and thus
undetectable, concentrations (32, 33).
Based on preliminary analysis of virus preparations at 8 days post
electroporation, which demonstrated complete reversion of the CRE(2C) of CVB3-CKO
to that of wt, it was important to determine if we were able to detect an intermediate
population at an earlier time-point or if the reversions appeared to occur simultaneously.
If the reversions did appear to occur simultaneously, it would suggest that the structure
provided by the CRE(2C) provided an increase in viral fitness within the cellular
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environment which would allow for more efficient replication when compared to the CKO
mutants. Indeed, when analyzing earlier time-points, it became clear that only after 8
days of replication post-electroporation in HeLa cells were we able to detect a complete
reversion of the CRE(2C) to wt sequence (Fig. 7). Complete reversions were also found
to occur in CVB3-TD50-CKO electroporated HeLa cells at day 8, and at day 20 posttransfection of CVB3-CKO T7 transcribed RNA in both the spleen and heart of mice
(Fig. 7). Important to note at this juncture is that when considering the possibility of
compensatory mutations, analysis of GenBank data demonstrated that only one
compensatory mutation was reported out of 429 available HEV-B sequences (Fig. 9).
This further supported the possibility of complete reversion of all 16 introduced mutations
in the region of the CRE(2C), as well as the hypothesis that the structure is important for
other functions besides that of VPg uridylylation. Finally, to complete these studies, it
was important to determine at what point in replication 5’ TDs evolved in the CVB3-CKO
population. We expected that TD’s were evolving prior to reversion of the CRE(2C) to
wt: were reversions to occur prior to TD formation, we would have expected a return to a
wt cytopathic phenotype but this was not observed. Indeed, 5’ TDs were found to occur
between days 1 and 8 post-electroporation of HeLa cells and this correlated with a slight
decrease in viral RNA titer over time (based on RT-qPCR assays) characteristic of a
low-level persistent replication (Fig. 10).
Taken together, the data presented in chapters 2 and 3 demonstrated that wt
CVB3 is replication competent without a functional CRE(2C) and that this structure is not
required for CVB-TD replication. Further, it is clear that 5’ TDs form during the
replication of CVB3-CKO and these TD mutations occur prior to a complete reversion of
the 16 mutations introduced in the CRE(2C) to that of a wt sequence. These findings
describe a new aspect of enteroviral biology and suggest that the CRE(2C) is important
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in enteroviral replication with a function(s) other than providing a template for VPg
uridylylation. Future work will be important to elucidate other functions of the CRE(2C)
which may include, among other things, providing a structure for the binding and
translocation of the initiation complex to the genomic termini for replication. It will be
important to verify that VPg remains attached at the 5’ genomic terminus of the CVB3CKO viruses and to determine if an altered positive to negative strand ratio exists in
these populations. Further, a more thorough investigation to determine the presence of
intermediate populations during the reversion of the CRE(2C) to a wt sequence is
warranted. This may be accomplished by techniques such as deep sequencing or RNA
sequencing.
Chapter 4 of this dissertation, though unrelated to the work described in
chapters 2 and 3, is connected to the others in that it presents the characterization of
another novel finding in microbiology: the characterization of a small-molecule
antibacterial agent, creatinine hydrochloride (CRN-HCl). The experiments discussed in
chapter 4 enhance and extend work previously completed (47), and demonstrate the
broad antibacterial activity of CRN-HCl in diverse media while simultaneously
demonstrating its lack of activity on fungi (Fig. 11). Furthermore, the experiments
presented in chapter 4 demonstrate that addition of CRN-HCl to growth media is more
effective at preventing bacterial growth than is the traditional SDA (Fig. 12) and may be
a cost effective alternative to use of this medium. Finally, the lack of antifungal activity
makes CRN-HCl an excellent candidate for isolation of diverse yeasts and molds, some
of which may have clinical importance or be producers of new antibiotics that can help
combat the growing concern of antimicrobial resistance (Fig. 13). Future work exploring
CRN-HCl should include experiments to understand the mechanism of action of this
small molecule. Recent work in the laboratory (unpubl. data) indicates that bacteria can
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develop resistance to CRN-HCl; whether this involves over-expression of proteins
involved in the proton motive force as suggested in previous work (47, 120), or some
other mechanism, remains to be studied. Once more thoroughly understood, many uses
for CRN-HCl outside of the laboratory can be envisioned to include addition of this
compound to topical antibiotics which should prevent infection and, perhaps, expedite
wound healing.
Together, the data presented in this dissertation describe novel and important
developments in the fields of virology and microbiology. The work outlined in chapters 2
and 3 of this dissertation demonstrate that not only is the replication of CVB3-TD50 not
affected when the CRE(2C) was mutationally disrupted, but surprisingly, CVB3-CKO is
replication competent and rapidly evolves 5’ terminal deletions prior to a complete
reversion of the mutated sequence back to that of wt. Therefore, the findings described
in chapters 2 and 3 of this dissertation elegantly illustrate that there is still new
knowledge to be gained in the field of enteroviral biology regarding the initiation and
replication of the CVB-TDs, and the HEV in general, and further demonstrate that
studying aspects of enteroviral biology using just one system (e.g., the cell free system)
can mask otherwise salient data. The work outlined in chapter 4 of this dissertation
demonstrates that a small molecule, CRN-HCl, a natural vertebrate metabolic waste
product once thought to have no biological function, is a potent inhibitor of bacterial
growth. Creatinine-HCl is useful in the laboratory to suppress bacterial growth in mixed
samples, allowing for the outgrowth of slower growing fungi, which presents a variety of
applications such as isolation of antibiotic producing fungi. Therefore, the findings
described in chapter 4 extend previous findings (47) and illustrate that the function of
many molecules produced naturally should not be taken for granted. While there is still
much work to be done in all aspects of this dissertation, the data presented here provide
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an important framework for further experimentation in the fields of both enteroviral
biology and microbiology.
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Appendix A: Primer optimization and determination of RT-qPCR Efficiency

Primer optimization was done using temperature gradients to determine the
optimal annealing temperatures for primer pairs 4523Rev and 2B1, 2C2 and 2C7,
Pin5End1 and E3, Pin5End5 and E3, Pin and SReturn, S4 and E3Sub, and S5 and
SReturn (Table 1;2). Following determination of optimal annealing temperatures, PCR
was done with decreasing 10 –fold dilutions of cDNA clones of wt CVB3 to determine the
limits of detection at the optimized temperatures. For RT-qPCR efficiency, 3 different
known concentrations of T7 transcribed RNA prepared from infectious CVB3 cDNA
clones was added to RT reactions with primer E3(Table 1). Following ethanol
precipitation, q-PCR was run on each RT reaction and the efficiency was calculated to
determine the number of cDNA copies detected per RNA molecule added to the initial
reaction. The following pages contain the figures showing these optimizations.
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FIG. A1. Primer optimization and efficiency of primers to amplify the CVB3 CRE(2C)
genomic region. Prior to amplifying the CRE(2C) region of the poorly replicating mutant
viruses, optimization and limit of detection experiments were performed. (A) A temperature
gradient was run with the primer pair 4523Rev and 2B1 in order to determine the optimal
annealing temperature for these primers and amplimers were run on a 2% agarose gel. Lane
A9 indicates the optimal annealing temperature for 4523Rev and 2B1 to be 520C. (B) The
process for 4523Rev and 2B1 was repeated for primers 2C2 and 2C7 to determine the
optimal annealing temperature for this primer pair. Lane B7 indicates the optimal annealing
temperature for 2C2 and 2C7 to be 540C (C) Following determination of optimal annealing
temperatures for both pairs, a limit of detection experiment was done using decreasing input
of T7 RNA into RT reactions with primer E3, followed by nested amplification using primers
4523Rev and 2B1, followed by 2C2 and 2C7 to determine how many copies of cDNA could
be detected using this method; between. Lane C4 indicates that the limit of detection for the
nested PCR to amplify the CRE(2C) region is on the order of 10,000 copies of cDNA.
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FIG. A2. Primer optimization and efficiency of primers to detect 5’ terminal deletions
in RNA. Prior to amplifying the 5’NTR to detect viral RNA in preparations, optimization and
limit of detection experiments were performed. (A) A temperature gradient was run with
the primer pair S4 and E3Sub in order to determine the optimal annealing temperature for
these primers; amplimers were run on a 2% agarose gel. Lane A5 indicates the optimal
annealing temperature for S4 and E3Sub to be 560C (B) The process was repeated for
primers S5 and SReturn to determine the optimal annealing temperature for this primer
pair. Lane B6 indicates the optimal annealing temperature for primers S5 and SReturn to
be 600C; higher temperatures were acceptable as well (C) Following determination of
optimal annealing temperatures for both pairs, a limit of detection experiment was done
using decreasing input of T7 RNA into RT reactions with primer E3, followed by nested
amplification using primers S4 and E3Sub, followed by S5 and SReturn to determine how
many copies of cDNA could be detected using this method. Lane C5 indicates that the
limit of detection of approximately 100 copies could be detected.
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FIG. A3. Primer optimization and efficiency of primers to detect 5’ terminal deletions
in RNA. Prior to amplifying the very 5’ termini to determine of deletions were occurring in
CVB3-CKO, primers were optimized for efficient. (A) A temperature gradient was run with
the primer pair Pin5End1 and E3, (B) primer pair Pin5End5 and E3, and (C) primers Pin
and SReturn following amplification with Pin5End primers and E3. (A-C) Amplimers were
analyzed on 2% agarose gels to determine optimal annealing temperatures for subsequent
reactions. The optimal annealing temperature for primers Pin5End1 and E3 was
determined to be 640C (lane A3), 640C for primers Pin5End5 and E3 (lane B3), and 530C
for primers Pin and SReturn (lane C6). (D) Following determination of optimal annealing
temperatures for all pairs, a limit of detection experiment was done using decreasing input
of T7 RNA into RT reactions with primer E3, followed by nested amplification using primers
Pin5End1 and E3 or Pin5End5 and E3, followed by Pin and SReturn to determine how
many copies of cDNA could be detected using this method; approximately 400 copies with
P5End1 (lane D4) and 1,000 copies with Pin5End5 (lane D11).
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FIG. A4. Determination of the efficiency of RT reactions. To determine the
efficiency of the reverse transcription reactions with the primary primer used in
the RT reactions, E3, RT reactions were set up with increasing concentrations
of T7 transcripts prepared from the wt CVB3 infectious cDNA clone;
concentrations cover a span of five logs from 10⁵ to 10⁹ copies of T7 RNA.
Reactions were repeated three times each. (A) Following quantitative
reactions, the ratio of detected cDNA to input RNA was calculated and graphed,
demonstrating a near linear efficiency of 52% regardless of the input RNA. (B)
Comparing detected copies of cDNA to input RNA again demonstrates a near
linear efficiency of the RT reaction independent of input concentration.

